ICARIIN

/ INGREDIENTS / By
  1. A combined chitosan/nano-size hydroxyapatite system for the controlled release of icariin
  2. A comparative study of mechanical strain, icariin and combination stimulations on improving osteoinductive potential via NF-kappaB activation in osteoblast …
  3. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis
  4. A natural flavonoid glucoside, icariin, regulates Th17 and alleviates rheumatoid arthritis in a murine model
  5. A new bone repair scaffold combined with chitosan/hydroxyapatite and sustained releasing icariin
  6. A novel antagonistic role of natural compound icariin on neurotoxicity of amyloid β peptide
  7. A novel approach to utilize icariin as icariin-derived ecm on small intestinal submucosa scaffold for bone repair
  8. A novel icariin type flavonoid from Epimedium pseudowushanense
  9. A sensitive and specific indirect competitive enzyme‑linked immunosorbent assay for the detection of icariin
  10. A simultaneous determination of ferulic acid and icariin in the Li’ankang tablet by HPLC
  11. A study on PLGA sustained release icariin/titanium dioxide nanotube composite coating
  12. A Traditional Chinese Medicine–icariin-Enhances the Effectiveness of Bone Morphogenetic Protein 2
  13. AB045. Therapeutic potential of icariin in combination with PDE5 inhibitor on penile atrophy and erectile dysfunction in a rat model of post-prostatectomy
  14. AB117. Efficacy and mechanism of combination therapy using icariin and daily sildenafil citrate for the treatment of erectile dysfunction in a rat model of bilateral …
  15. Absorption and metabolism of icariin in different osteoporosis rat models
  16. Absorption and metabolism of icariin in the in situ singlepass perfused rat intestinal model
  17. Absorption and utilisation of epimedin C and icariin from Epimedii herba, and the regulatory mechanism via the BMP2/Runx2 signalling pathway
  18. Absorption kinetics of icariin solid lipid nanoparticles in rat’s intestines
  19. Absorption mechanism of icariin across Caco-2 monolayer model
  20. Activation of endoplasmic reticulum stress is involved in the activity of icariin against human lung adenocarcinoma cells
  21. Activation of Nrf2 signaling by icariin protects against 6‐OHDA‐induced neurotoxicity
  22. Adsorption and Purification of Total Flavonoids and icariin on Herba Epimedii. by Macroprous Resin [J]
  23. Advances in neuroharmacological effects and molecular mechanisms of icariin
  24. Advances in study on icariin extraction, separation, and its anti-tumor mechanism.
  25. Amelioration of icariin for the epididymis impairment induced by streptozocin (STZ) in rats
  26. An Experimental Study of Effects of icariin on Increasing Smad4 mRNA Level in Osteoblast Cells of OVX Rats
  27. An experimental study on the use of icariin for improving thickness of thin endometrium
  28. An inhibitor of cathepsin K, icariin suppresses cartilage and bone degradation in mice of collagen-induced arthritis
  29. An open-label pilot study of icariin for co-morbid bipolar and alcohol use disorder
  30. An outline for the pharmacological effect of icariin in the nervous system
  31. Analysis of biliary excretion of icariin in rats
  32. Analysis of genes expression profiles of icariin in treating osteoporosis of ovariectomized rats
  33. Analysis of icariin and epimedin C in cigarette and its smoke particulate matter by LC/ESI/MS.
  34. Analysis of the osteogenetic effects exerted on mesenchymal stem cell strain C3H10T1/2 by icariin via MAPK signaling pathway in vitro
  35. Analysis of Uncertainty for Determination of the icariin in Bushen Oral Liquid by HPLC [J]
  36. Angiogenic and MMPs modulatory effects of icariin improved cutaneous wound healing in rats
  37. Anti-apoptotic effect of icariin on renal tubular epithelial cell in SHR
  38. Antibacterial and osteoinductive properties of icariin-metronidazole/calcium phosphate cement sustained release system
  39. Anti-cancer mechanism of the flavonoid icariin (ICA) and its derivative ICT on the tumor microenvironment (46.41)
  40. Anti-cancer properties of the naturally occurring aphrodisiacs: icariin and its derivatives
  41. Antidepressant effects of icariin in prenatally stressed offsprings
  42. Antidepressant-like activity of icariin mediated by group I mGluRs in prenatally stressed offspring
  43. Antidepressant-like effect of icariin and its possible mechanism in mice
  44. icariin-from-epimedium-brevicornum.html” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=http://www.biomedres.info/biomedical-research/antifatigue-properties-of-icariin-from-epimedium-brevicornum.html&source=gmail&ust=1579280816297000&usg=AFQjCNG-B2X8Co32qhm3hNQjSg4NgK9wCQ”>Anti-fatigue properties of icariin from Epimedium brevicornum
  45. Anti-fatigue Properties of icariin Isolated from Epimedium Brevicornum Maxim in Mice
  46. Antigen-adjuvant effects of icariin in enhancing tumor-specific immunity in mastocytoma-bearing dba/2j mice
  47. Anti-Left ventricular remodeling effects of icariin in SHR by decreasing MMP-9 levels
  48. Anti-myeloma effects of icariin are mediated through the attenuation of jak/stat3-dependent signaling cascade
  49. Antiosteoporotic activity of icariin in ovariectomized rats
  50. Antiosteoporotic effect of icariin in ovariectomized rats is mediated via the Wnt/β-catenin pathway
  51. Antioxidant effects of icariin and icariside Ⅱ in vitro [J]
  52. Antioxidative protective effect of icariin on the FeSO4/H2O2-damaged human sperm based on confocal raman micro-spectroscopy
  53. Anti-proliferative and cytoskeleton-disruptive effects of icariin on HepG2 cells
  54. Anti-proliferative efficacy of icariin on HepG2 hepatoma and its possible mechanism of action
  55. Application of icariin in the preparation of drugs for the treatment of low-androgen infertility in epididymis
  56. Application of near infrared spectroscopy for the rapid determination of epimedin A, B, C and icariin in Epimedium
  57. Application of uniform design for preparation of icariin solid lipid nanoparticles
  58. Arsenic trioxide and icariin show synergistic anti-leukemic activity
  59. Assay of icariin, psoralen and isopsoralenin in Xianling Gubao Dripping Pill by RP-HPLC [J]
  60. Atomic Force Microscopic Study on icariin Induced Osteogenic Differentiation of Human Umbilical Cord Mesenchymal Stem Cells [J]
  61. Attenuation of LPS-induced inflammation by ICT, a derivate of icariin, via inhibition of the CD14/TLR4 signaling pathway in human monocytes
  62. Autologous Freeze-Dried, Platelet-Rich Plasma Carrying icariin Enhances Bone-Tendon Healing in a Rabbit Model
  63. Bioactive glass based scaffolds coated with gelatin for the sustained release of icariin
  64. Bioactive molecule icariin inhibited proliferation while enhanced apoptosis and autophagy of rat airway smooth muscle cells in vitro
  65. Bioactive Study on Mixtures of Epimedin C and icariin Monomers with Invariant Molarity to Zebrafish Osteoporosis Model
  66. BMP-2 and icariin synergistically promote p38MAPK-mediated cardiomyocyte differentiation of mesenchymal stem cells via enhanced NOX4-driven ROS generation
  67. Bone mass improved effect of icariin for postmenopausal osteoporosis in ovariectomy-induced rats: a meta-analysis and systematic review
  68. Bone-targeting drug delivery system of biomineral-binding liposomes loaded with icariin enhances the treatment for osteoporosis
  69. Cartilage tissue engineering via icariin and adipose-derived stem cells in fibrin scaffold
  70. Cathepsin K inhibitor, icariin, increases the healing potential and biomechanical properties of femoral neck in a mice fractured model
  71. Change of CD4+ CD25+ Foxp3+ treg cells and foxp3 expression in a mouse model of asthma and the effects of icariin.
  72. Change of icariin content in five Epimedium species by heating process
  73. Changes in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins
  74. Characterization and Dissolution Studies of icariin-β-cyclodextrin (β-CD) Inclusion Complex
  75. Characterization of Icarrin and icariin-2-Hydroxypropyl-beta-Cyclodextrin Inclusion Complex-Loading Poly (L-Lactic Acid) Scaffolds
  76. China Ginger Root Powder-Pure natural epimedium brevicornum extract pe/epimedium sagittatum extract icariin 20%-Ningbo J&S Botanics
  77. Chondroprotective effects and multi-target mechanisms of icariin in IL-1 beta-induced human SW 1353 chondrosarcoma cells and a rat osteoarthritis model
  78. Clinical Comparative Study of icariin Complex Versus Lidocaine for Treatment of Primary Premature Ejaculation [J]
  79. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis
  80. Combination of icariin and bone morphogenetic protein 2: A potential osteogeniccompound for bone tissue engineering
  81. Combination of icariin and oleanolic acid attenuates in vivo and in vitro glucocorticoid resistance through protecting dexamethasone-induced glucocorticoid …
  82. Combination of mesenchymal stem cell injection with icariin for the treatment of diabetes-associated erectile dysfunction
  83. Combination treatment of icariin and L-DOPA against 6-OHDA-lesioned dopamine neurotoxicity
  84. Comparative effects of er-xian decoction, epimedium herbs, and icariin with estrogen on bone and reproductive tissue in ovariectomized rats
  85. Comparative effects of hispidulin, genistein, and icariin with estrogen on bone tissue in ovariectomized rats
  86. Comparative pharmacokinetics of icariin in plasma after oral administration of Er-Xian decoction or pure icariin in rats
  87. Comparative pharmacokinetics study of icariin and icariside II in rats
  88. Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim
  89. Comparative studies on protective effects on reproduction of icariin and the substance extracted from the semen cuscutae in rats with partial androgen deficiency
  90. Comparative study on effect of icariin and genistein on proliferation and mineralization of osteoblasts in vitro
  91. Comparative study on effect of icariin and genistein on proliferation and mineralization of osteoblasts in vitro [J]
  92. Comparative study on the osteogenic differentiation of rat bone marrow stromal cells effected by icariin and icariside II
  93. Comparison between HPLC and HPTLC densitometry for the determination of icariin from Epimedium koreanum extracts
  94. Comparison between icariin and genistein in osteogenic activity of marrow stromal cells
  95. Comparison of the pharmacokinetic characteristics of icariin and icarisideⅡafter administration of icariin monomer and Epimedium flavonoids in Wistar rats [J]
  96. Comparison on the Content of icariin in Kanggu Zengsheng Pills on Sale [J]
  97. Comparison research with icariin and genistein by anti-inflammatory reaction and angiogenesis pathway to inhibit bone loss on ovariectomized rats
  98. Compound of icariin, astragalus, and puerarin mitigates iron overload in the cerebral cortex of Alzheimer’s disease mice
  99. Conjugated icariin promotes tissue-engineered cartilage formation in hyaluronic acid/collagen hydrogel
  100. Construction of a novel catalysis system for clean and efficient preparation of Baohuoside I from icariin based on biphase enzymatic hydrolysis
  101. Construction of a small-caliber tissue-engineered blood vessel using icariin-loaded β-cyclodextrin sulfate for in situ anticoagulation and endothelialization
  102. Content Comparison of icariin between Herba Epimedii and Dispensing Granules [J]
  103. Content Determination of icariin in Yishenkang Granules by RP-HPLC [J]
  104. Controlled delivery of icariin on small intestine submucosa for bone tissue engineering
  105. Controlled release in vitro of icariin from gelatin/hyaluronic acid composite microspheres
  106. Coordinate regulatory osteogenesis effects of icariin, timosaponin B II and ferulic acid from traditional Chinese medicine formulas on UMR-106 osteoblastic cells and …
  107. Correction: icariin and icaritin recover UVB-induced photoaging by stimulating Nrf2/ARE and reducing AP-1 and NF-κB signaling pathways: a comparative study on …
  108. Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia …
  109. Design and Synthesis of icariin Analogues as a PDE-5 inhibitors
  110. Design, preparation, surface recognition properties, and characteristics of icariin molecularly imprinted polymers
  111. Detemination of icariin in the Zhonghuadalishen by HPLC [J]
  112. Detennination of icariin in Bushenqiangshen Capsules by HPLC Method
  113. Determination of Content of icariin in Xianrong Gejie Oral by HPLC [J]
  114. Determination of dioscin and icariin in Chuanlong Guci Tablet by HPLC [J]
  115. Determination of Dissolution Amount of icariin in Different Particle Sizes of Epimedium by HPLC [J]
  116. Determination of epimedin C and icariin in Herba Epimedii by HPLC
  117. Determination of epimedin C and icariin in Xianling Guobao Capsules by RP-HPLC [J]
  118. Determination of equilibrium solubility of icariin and its apparent oil/water partition coefficient
  119. Determination of geographical origin and icariin content of Herba Epimedii using near infrared spectroscopy and chemometrics
  120. Determination of icariin and adenosine in Cordyceps Vigorine Tablet by HPLC
  121. Determination of icariin and Levamisole Hydrochloride in Wan Ru Kang Sample by Ion-pair Chromatography
  122. Determination of icariin and metabolites in rat serum by capillary zone electrophoresis: rat pharmacokinetic studies after administration of icariin
  123. Determination of icariin and Paeonol in Nan Bao Capsules by RP-HPLC
  124. Determination of icariin and stilbene glycoside in anshenbunaoye by HPLC [J]
  125. Determination of icariin and tanshinone IIA in Jiliu Huaxiao Granules by HPLC.
  126. Determination of icariin by HPLC [J]
  127. Determination of icariin Concentration in a tablet by HPLC
  128. Determination of icariin content in gengnianling capsule by HPLC [J]
  129. Determination of icariin Content in Gengnianshu Tables by HPLC
  130. Determination of icariin Content in Ruhexiao Capsule by HPLC
  131. Determination of icariin Content in Shenrongqiangshen Capsule by HPLC [J]
  132. Determination of icariin content in Yishen granules by HPLC [J]
  133. Determination of icariin contents in Bushen Nuanyang granules by HPLC
  134. Determination of icariin Contents in Different Plant Parts of Epimedium Plants in Guizhou by HPLC [J]
  135. Determination of icariin Contents in Epimedium brevicornum Maxim. with Substitute Reference Substance [J]
  136. Determination of icariin Contents in Jianrumei Oral Liquid by HPLC
  137. Determination of icariin Contents in Nanbao Capsules by HPLC [J]
  138. Determination of icariin Contents in Qianlieshu Granule by HPLC
  139. Determination of icariin Epimedium from Different Haital in China by HPLC [J]
  140. Determination of icariin from Wantong Jingu Tablets by HPLC
  141. Determination of icariin in Ancient Han Health-Keeping Extract by HPLC
  142. Determination of icariin in Bikang capsules by HPLC
  143. Determination of icariin in Bushen Capsule [J]
  144. Determination of icariin in Bushen Fangchuan Film-coaling Tablets by HPLC
  145. Determination of icariin in Bushen Huoxue Tablets by HPLC
  146. Determination of icariin in Bushen Qiangshen Tablets by HPLC
  147. Determination of icariin in Bushen Qiangshen Tablets by RP-HPLC [J]
  148. Determination of icariin in bushenqiangshen capsule in high-performance liquid chromatography with fluorescence detection by precolumn chelation with aluminum
  149. Determination of icariin in Bushenqiangshen Capsules by RP-HPLC
  150. Determination of icariin in Bushenyishou Capsules by High Performance Liquid Chromatography
  151. Determination of icariin in Bushenyishou Capsules by HPLC [J]
  152. Determination of icariin in Butianling tablets by HPLC [J]
  153. Determination of icariin in Chuan Long Gu Ci Tablets by HPLC
  154. Determination of icariin in Chuankezhi Injection by HPLC [J]
  155. Determination of icariin in Chuanlong Guci Pian by HPLC.
  156. Determination of icariin in compound Erxiancao capsule by HPLC
  157. Determination of icariin in Compound Sanqi Mingmu Capsules by HPLC
  158. Determination of icariin in Cortex Eucommia Zhuanggu Capsules by RP-HPLC
  159. Determination of icariin in Cuyun Guanzhuye by HPLC [J]
  160. Determination of icariin in Erxianzengjing mixture by HPLC
  161. Determination of icariin in Fuguigutong Capsule by HPLC
  162. Determination of icariin in Funingkang Soft Capsule by HPLC
  163. Determination of icariin in Geng Nian San Hao Capsule by HPLC
  164. Determination of icariin in Gengshu’an Granules by RP-HPLC
  165. Determination of icariin in Guilubushen capsules by HPLC
  166. Determination of icariin in Guilubushen Pills by HPLC [J]
  167. Determination of icariin in Gukangbao Granules (Sugar Free) by RP-HPLC
  168. Determination of icariin in gushukang granula by HPLC
  169. Determination of icariin in Gusongbao Effervescent Tablets by HPLC
  170. Determination of icariin in Haimabaji Capsules by HPLC
  171. Determination of icariin in Hanshui Capsule by HPLC
  172. Determination of icariin in health food by SPE-HPLC
  173. Determination of icariin in Herba Epimedium by reversed-phase high performance liquid chromatography [J]
  174. Determination of icariin in HuiChun Capsules by RP-HPLC [J]
  175. Determination of icariin in Huobu Capsule by HPLC
  176. Determination of icariin in Jianbu Guanjie Capsule by HPLC [J]
  177. Determination of icariin in Jiangu Capsules by RP-HPLC
  178. Determination of icariin in Jiawei Wu-Zi-Yan-Zong Pill by HPLC
  179. Determination of icariin in JieXinTong Capsules by RP-HPLC [J]
  180. Determination of icariin in Jiexintong tablets by HPLC [J]
  181. Determination of icariin in Kanggu Zengsheng Pills by HPLC [J]
  182. Determination of icariin in Kanggu Zengsheng tablet by HPLC
  183. Determination of icariin in Kangguzengsheng Pills by HPLC
  184. Determination of icariin in Kanggu-Zengsheng tablet by HPLC [J]
  185. Determination of icariin in Kangguzengsheng Tablets by HPLC
  186. Determination of icariin in Kangguzengsheng Tablets by HPLC [J]
  187. Determination of icariin in Laonian Kechuan Tablets by HPLC [J]
  188. Determination of icariin in Laoniankechuan tablets by HPLC [J]
  189. Determination of icariin in Luweibian Wine by RP-HPLC [J]
  190. Determination of icariin in Naogongyang Granule by RP-HPLC
  191. Determination of icariin in Naoyiyuan capsules
  192. Determination of icariin in Qianlie Huichun Concentrated Pills by HPLC [J]
  193. Determination of icariin in Qianlie Shule Granules by HPLC [J]
  194. Determination of icariin in Qianliekang Capsule by Reversed Phase High-Performance Liquid Chromatography
  195. Determination of icariin in Qianliekangshu Capsule by HPLC [J]
  196. Determination of icariin in Qianlieshule Capsule by HPLC
  197. Determination of icariin in Qiyang Capsules by HPLC
  198. Determination of icariin in Qizierxian capsule by High performance Liquid Chromatography [J]
  199. Determination of icariin in rat plasma by reverse‐phase high‐performance liquid chromatography after oral administration of a lipid‐based suspension of Epimedium …
  200. Determination of icariin in rat plasma in different time by improved RP-HPLC after oral administration of epimedium compound preparation
  201. Determination of icariin in Ruhe Sanjie Capsules by HPLC
  202. Determination of icariin in Rujiling Tablets by HPLC
  203. Determination of icariin in Ruzengning Capsule by Solid Phase Extraction/Quantitative Nuclear Magnetic Resonance Spectroscopy
  204. Determination of icariin in Ruzenning Tablets by Column Chromatography-HPLC [J]
  205. Determination of icariin in sanitarian food by HPLC [J]
  206. Determination of icariin in sanziqiangshen capsule by HPLC [J]
  207. Determination of icariin in Shengbaiyin by RP-HPLC [J]
  208. Determination of icariin in Shenglixiong Capsule by RP-HPLC
  209. Determination of icariin in Shenjiang Suoyang Yiqi Tables by HPLC [J]
  210. Determination of icariin in Shenqi Anshen Capsule by HPLC [J]
  211. Determination of icariin in Shenxiongjing oral liquid by TLC
  212. Determination of icariin in Shuxin Tablets by HPLC
  213. Determination of icariin in supercritical fluid extracts of epimedium by RP-HPLC
  214. Determination of icariin in Tenghuang Jiangu granules by HPLC [J]
  215. Determination of icariin in the Anshenbunaoye by HPLC [J]
  216. Determination of icariin in Tian’e bushen oral liquid by HPLC
  217. Determination of icariin in Wujia Baozhen product by HPLC
  218. Determination of icariin in Xianlingubao Tablets by HPLC [J]
  219. Determination of icariin in Xianyang Xiongfeng Capsule by HPLC
  220. Determination of icariin in Yangguang Capsule by HPLC combined with Solid-phase Extraction [J]
  221. Determination of icariin in Yangqiang Baoshen Pills by Column Chromatography-HPLC [J]
  222. Determination of icariin in Yanzong Yuzi Capsules by HPLC [J]
  223. Determination of icariin in Yihechun Capsules by HPLC [J]
  224. Determination of icariin in Yijing Pill by HPLC [J]
  225. Determination of icariin in Yinyangsu capsules by HPLC [J]
  226. Determination of icariin in Yishen Gao by High Performance Liquid Chromatography
  227. Determination of icariin in Yishen Kanggu tablets by RP-HPLC
  228. Determination of icariin in Yishenjiangu Capsule by HPLC
  229. Determination of icariin in Yishenling Capsules by HPLC [J]
  230. Determination of icariin using HPLC with chemiluminescence detection
  231. Determination of icariin, hesperidin and paeoniflorin in Bufei Yishen Granules by HPLC [J]
  232. Determination of plasma aglycon of icariin in Beagle dogs by liquid chromatography-tandem mass spectrometry [J]
  233. Determination of Plasma Protein Binding Rates of icariin by Ultrafiltration Coupled with HPLC
  234. Determination of psoralen, isopsoralen, icariin and baohuoside I in Shengrong Yanling Pill by HPLC elution method.
  235. Determination of rat urinary metabolites of icariin in vivo and estrogenic activities of its metabolites on MCF-7 cells
  236. Determination of the Content of icariin in Shengjing Capsule by HPLC [J]
  237. Determination of the Content of icariin in Tongbizhitong Granules by HPLC [J]
  238. Determination of the Contents of icariin in Gushen Pills with HPLC
  239. Determination of the pKa value of icariin and its content in the Chinese herb medicine epimedium grandiflorum morr. by capillary electrophoresis
  240. Determination of the solubility, dissolution enthalpy and entropy of icariin in water, ethanol, and methanol
  241. Determination of Total Flavonoids and icariin in Yulin Mixture
  242. Determination the Content of icariin in Fufangxuanju Capsule by HPLC [J]
  243. Determination the Content of icariin in Gengnianling Capsule by HPLC
  244. Determination the Content of icariin in Qianliehuichun Capsules by HPLC [J]
  245. Determination the content of icariin in Yigu Capsules by HPLC
  246. Determination the content of icariin in Yinyangsuo Granules by HPLC
  247. Determine the structure of phosphorylated modification of icariin and its antiviral activity against duck hepatitis virus A
  248. Determinnation on the contents of icariin in Kanggu-zengsheng tablets by HPLC
  249. Development and Validation of a LC–ESI–MS Assay for Determination of icariin in Rat Plasma after Administration of Herba Epimedii
  250. Development and validation of a TLC-densitometric method for the simultaneous quantitation of icariin and l-arginine from commercial formulations
  251. Development and validation of nonaqueous capillary electrophoresis method for simultaneous estimation of icariin, icariside II, and epimedin K in Epimedium leaves
  252. Development effect of icariin on the structure and function of mouse main organs
  253. Development of a One-Step Lateral Flow Immunoassay for Rapid Detection of icariin
  254. Development of an injectable thiolated icariin functionalized collagen/hyaluronic hydrogel to promote cartilage formation in vitro and in vivo
  255. Development of Fluorescence-Linked Immunosorbent Assay for icariin
  256. Different molecular targets of icariin on bMSCs in CORT and OVX-rats
  257. Drug-drug interactions potential of icariin and its intestinal metabolites via inhibition of intestinal UDP-glucuronosyltransferases
  258. Dual-delivery of vancomycin and icariin from an injectable calcium phosphate cement-release system for controlling infection and improving bone healing
  259. Dynamic content changes of active constituent icariin in Er-xian decoctum detected by HPLC method
  260. ED 16. Effects of icariin and IcarisideⅡon eNOS expression and NOS activity in porcine aorta endothelial cell
  261. ED 17. Effects of icariin on improving erectile function in Streptozotocin-induced diabetic rats
  262. Effect and mechanism of icariin on myocardial ischemia-reperfusion injury model in diabetes rats
  263. Effect of chinese traditional herb Epimedium grandiflorum C.Morren and its extract icariin on osteoarthritis via suppressing NF-B pathway
  264. Effect of Clarificant Chitosan on the Content of icariin in the Refined Liquid
  265. Effect of different fatty acids on icariin in vivo and in vitro system solution
  266. Effect of Hyperin and icariin on steroid hormone secretion in rat ovarian granulosa cells
  267. Effect of icariin and its metabolites on the production of cytokines by THP-1 cells.
  268. Effect of icariin in combination with daily sildenafil on penile atrophy and erectile dysfunction in a rat model of bilateral cavernous nerves injury
  269. Effect of icariin in Increasing Apoptosis of Cervical Cancer TC-1 Cells
  270. Effect of icariin on ability to prevent endothelial dysfunction in hypercholesterolemia rabbit
  271. Effect of icariin on allogeneic skin transplantation in mice [J]
  272. Effect of icariin on apoptosis and expression of Fas, Fas ligand, B cell lymphoma, and Bcl-2-associated X protein in CD4+ T lymphocytes from patients with …
  273. Effect of icariin on apoptosis in hippocampal neurons cultured in high glucose
  274. Effect of icariin on apoptosis of spermatogenic cells in alcohol-treated testis of mice
  275. Effect of icariin on bone destruction and serum RANKL/OPG levels in type II collagen-induced arthritis rats
  276. Effect of icariin on bone formation during distraction osteogenesis in the rabbit mandible
  277. Effect of icariin on cell proliferation and the expression of bone resorption/formation-related markers in human periodontal ligament cells
  278. Effect of icariin on Con A-induced BRL-3A cell injury in vitro
  279. Effect of icariin on cyclic GMP levels and on the mRNA expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in penile cavernosum
  280. Effect of icariin on cyclic GMP levels and on the mRNA expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in penile cavernosum.
  281. Effect of icariin on engineered 3d-printed porous scaffolds for cartilage repair
  282. Effect of icariin on fracture healing in an ovariectomized rat model of osteoporosis
  283. Effect of icariin on Glucocorticoid Receptor Expression in Kidney Yang—deficiency Cells
  284. Effect of icariin on hypoxia induced vascular endothelial cells injury
  285. Effect of icariin on hypoxia/reoxygenation injury in neonatal rat cardiomyocytes
  286. EFFECT OF icariin ON INFLAMMATORY RESPONSE AND LEARNING AND MEMORY ABILITIES IN MICE WITH ALZHEIMER’S DISEASE
  287. Effect of icariin on intermediate and advanced activation of murine T lymphocytes in vitro
  288. Effect of icariin on Intimal Proliferation and Apoptosis of Vascular Smooth Muscle Cell after Vascular Injury in Rats [J]
  289. Effect of icariin on learning and memory abilities and activity of cholinergic system of senescence-accelerated mice SAMP10
  290. Effect of icariin on OPG/RANKL Gene and Protein Expression Influence of Mus Musculus Osteolysis Model [J]
  291. Effect of icariin on Osteoarthritis Fibroblast-Like Synoviocytes: An In Vitro Study
  292. Effect of icariin on osteoblastic differentiation gene expression of human periodontal ligament cells
  293. Effect of icariin on osteoclastic bone resorption and the mechanism
  294. Effect of icariin on Osteogenic Differentiation and Adipogenic Differentiation of Rat Bone Marrow Stromal Stem Cells
  295. Effect of icariin on proliferation and apoptosis of hepatocellular carcinoma SMMC-7721 cells
  296. Effect of icariin on Rats Femur Tissue in vitro [J]
  297. Effect of icariin on serum bone turnover markers expressions and histology changes in mouse osteoarthritis model
  298. Effect of icariin on the chondrogenesis of human adipose derived stem cells on poly (lactic-co-glycolic) acid/fibrin composite scaffold
  299. Effect of icariin on the Expression of GATA-4 by Bone Marrow Mesenchymal Stem Cells [J]
  300. Effect of icariin on the Expression of Matrix Metalloprotease-2 after Vascular Injury in Rats
  301. Effect of icariin on the expression of MMP-9 and CK mRNA in mouse osteoclasts.
  302. Effect of icariin on the expression of receptor activator nuclear factor-κB ligand and osteoprotegerin of human periodontal ligament cells
  303. Effect of icariin on the expression of transforming growth factor-beta 1 and bone morphogenetic protein-2 in the process of mesenchymal stem cells differentiation into …
  304. Effect of icariin on the mRNA and protein expression of NOS isoform in corpus cavernosum of castrated rats
  305. Effect of icariin on the mRNA expressions of Cbfalpha1, BMP2, BMP4 in rat osteoblasts
  306. Effect of icariin on the osteoarthritic knee of rabbits in the early stage
  307. Effect of icariin on the proteomic expression profile of bone microvascular endothelial cells of human femoral head against steroids-induced lesion
  308. Effect of icariin on the vasodilation function of renal artery in diabetic nephropathy rats
  309. Effect of icariin on tibial dyschondroplasia incidence and tibial characteristics by regulating P2RX7 in chickens
  310. Effect of icariin on UDP-glucuronosyltransferases in mouse liver
  311. Effect of icariin, diosgenin and genistein on proliferation and differentiation of newborn rat skull cells in vitro
  312. Effect of icariin/attapulgite/collagen type Ⅰ/polycaprolactone composite scaffold in repair of rabbit tibia defect
  313. Effect of oral administration of icariin on periodontitis associated alveolar bone resorption in an osteoporosis mouse model
  314. Effect of Solid State Fermentation of Herba Epimedii with Spergillus Niger on the Content of icariin and Assay
  315. Effect of the Compatibility of Panax notoginseng Saponinsn and icariin on Proliferation of Osteoblasts Cultured by High Glucose
  316. Effect of β-cyclodextrin complexation on solubility and enzymatic hydrolysis rate of icariin
  317. Effect of β-sitosterol and icariin on porcine spermatozoa capacitation in vitro.
  318. Effect on the content of icariin in Gubi Granules by the radiation of~(60) cobalt-γ ray
  319. Effects and interaction of icariin, curculigoside, and berberine in er-xian decoction, a traditional chinese medicinal formula, on osteoclastic bone resorption
  320. Effects and mechanisms of icariin on atherosclerosis
  321. Effects of dietary supplementation with icariin on growth performance, antioxidant capacity and non-specific immunity of Chinese mitten crab (Eriocheir sinensis)
  322. Effects of Different Extraction Methods on Total Flavonoids and icariin Contents of Herba Epimedii
  323. Effects of different processed products on the main ingredient of epimedin C and icariin of Epimedium wushanense
  324. Effects of different processed products on the main ingredient of epimedin C and icariin of Epimedium wushanense.
  325. Effects of EPCs Preconditioned by Syn-transplanting BMSc and icariin on AMI Rat’s Heart Function [J]
  326. Effects of Epimedin C and icariin on uterus of ovariectomized mice
  327. Effects of icariin (ICA) on Proliferation of Gastric Cancer Cell Line SGC-7901 [J]
  328. Effects of icariin and genistein on peak bone mass in rats
  329. Effects of icariin and icariside II on eNOS expression and NOS activity in porcine aorta endothelial cells
  330. Effects of icariin and icarisideⅡon eNOS expression and NOS activity in porcine aorta endothelial cells [J]
  331. Effects of icariin and nimodipine on behavioral changes in mice with transient cerebral ischemia/reperfusion
  332. Effects of icariin combined with Panax notoginseng saponins on ischemia reperfusion‐induced cognitive impairments related with oxidative stress and CA1 of …
  333. Effects of icariin combined with Panax notoginseng saponins on vascular dementia model rats and anti lipid peroxidation in brain [J]
  334. Effects of icariin in Isoproterenol induced Cardiotoxicity in Wistar Rats
  335. Effects of icariin of experimental IgA nephropathy in rats
  336. Effects of icariin on activation and proliferation of murine T lymphocytes in vitro [J]
  337. Effects of icariin on acute lung injury in mice induced by activation of the complement alternative pathway
  338. Effects of icariin on asthma mouse model are associated with regulation of prostaglandin D2 level
  339. Effects of icariin on Atherosclerosis and Predicted Function Regulatory Network in ApoE Deficient Mice
  340. Effects of icariin on autophagy and exosome production of bone microvascular endothelial cells
  341. Effects of icariin on Bcl-2 and Bax protein expressions and eosinophils apoptosis in bronchial asthmatic mice
  342. Effects of icariin on BDNF and TrkB of rats with focal cerebral ischemia-reperfusion injury
  343. Effects of icariin on beta-amyloid and neurotrophic factors in brain of mitochondrial deficiency model rats
  344. Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities
  345. Effects of icariin on Cyclic GMP and Cyclic AMP Levels in the Rabbit Corpus Cavernosum in vitro
  346. Effects of icariin on cytokine-induced ankylosing spondylitis with fibroblastic osteogenesis and its molecular mechanism
  347. Effects of icariin on erectile function and expression of nitric oxide synthase isoforms in castrated rats
  348. Effects of icariin on expression of BDNF and TrkB mRNA in natural aging rat hippocampus [J]
  349. Effects of icariin on expression of glucose regulated protein 78 in vascular smooth muscle cell induced by homocysteine
  350. Effects of icariin on expression of OPN mRNA and type I collegen in rat osteoblastsin vitro
  351. Effects of icariin on expression of the estrogen receptor beta mRNA of boneand different hypothalamic nuclei in ovariectomy rats [J]
  352. Effects of icariin on expression of transforming growth factor β_1 and type Ⅳ collagen in diabetic rat testis
  353. Effects of icariin on human bone marrow stromal stem cells differentiate and proliferate in vitro
  354. Effects of icariin on hypothalamic-pituitary-adrenal axis action and cytokine levels in stressed Sprague-Dawley rats
  355. Effects of icariin on IL-17-associated RANKL of Type Ⅱ Collagen-induced Arthritis in Mice [J]
  356. Effects of icariin on improving erectile function in streptozotocin‐induced diabetic rats
  357. Effects of icariin on inducing osteoclast formation and bone resorption in mouse bone marrow culture
  358. Effects of icariin on inflammation model stimulated by lipopolysaccharide in vitro and in vivo
  359. Effects of icariin on insulin resistance via the activation of AMPK pathway in C2C12 mouse muscle cells
  360. Effects of icariin on intracavernosal pressure and systematic arterial blood pressure of rat
  361. Effects of icariin on liver microsomal cytochrome P450 in rats with different ages
  362. Effects of icariin on long noncoding RNA and mRNA expression profile in the aortas of apoE-deficient mice
  363. Effects of icariin on orthodontic tooth movement in rats
  364. Effects of icariin on osteogenic differentiation of bone marrow stromal cells in beagle canine
  365. Effects of icariin on osteogenic differentiation of rat bone marrow mesenchymal stem cells [J]
  366. Effects of icariin on ovarian development in neonatal rats.
  367. Effects of icariin on ovarian function in d-galactose-induced aging mice
  368. Effects of icariin on ovariectomized osteoporotic rats
  369. Effects of icariin on partial vasoactive substances in monocrotaline-induced pulmonary arterial hypertension rat model
  370. Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells
  371. Effects of icariin on physiological properties of isolated small intestinal smooth muscle from the rabbit
  372. Effects of icariin on Proliferation and Differentiation of Osteoblasts from Chicken Embryo
  373. Effects of icariin on proliferation of vascular smooth muscle cell induced by ox-LDL via impacting MAPK signaling pathway
  374. Effects of icariin on reproductive functions in male rats
  375. Effects of icariin on the alkline phosphatase activity of human periodontal ligament cells inhibited by lipopolysaccharide
  376. Effects of icariin on the development of ovary and uterus in sexually matured female rats [J]
  377. icariin-on-the-differentiation-and-boneresorption-function-of-osteoclasts(d7ccea99-257d-413d-bb6e-4f82b713e353).html” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://scholars.cityu.edu.hk/en/publications/effects-of-icariin-on-the-differentiation-and-boneresorption-function-of-osteoclasts(d7ccea99-257d-413d-bb6e-4f82b713e353).html&source=gmail&ust=1579280816302000&usg=AFQjCNGeMUmpY10Im8DuM-dANDmA6GtSNw”>Effects of icariin on the differentiation and bone-resorption function of osteoclasts
  378. Effects of icariin on the erectile function and expression of nitrogen oxide synthase isoforms in corpus cavernosum of arterigenic erectile dysfunction rat model
  379. Effects of icariin on the Expression of Bone Morphogenetic Protein-2 in Osteoblasts
  380. Effects of icariin on the expression of ER, VEGF, and KDR in the endometrial cells of thin endometrium
  381. Effects of icariin on the expression of β-amyloid in hippocampus of SAMP10 in rapidly aging mice
  382. Effects of icariin on the osteogenic differentiation of bone marrow mysenchymal stem cells in vitro
  383. Effects of icariin on the proliferation and differentiation of MC3T3-E1
  384. Effects of icariin on the Proliferation and Osteogenic Differentiation of Human Periodontal Ligament Cells
  385. Effects of icariin on the proliferation, differentiation and maturation of rat calvarial osteoblasts in vitro
  386. Effects of icariin on the regulation of the OPG‑RANKL‑RANK system are mediated through the MAPK pathways in IL‑1β‑stimulated human SW1353 …
  387. Effects of icariin promotion on proliferation and osteogenic differentiation of human periodontal ligament stem cells
  388. Effects of icariin total flavonoids capsule on bone mineral density and bone histomorphometry in growing rats
  389. Effects of Tetramethylpyrazine and icariin on tibial dyschondroplasia incidence, tibial angiogenesis, performance and characteristics via regulating HIF-1α/VEGF …
  390. Effects of the Compatibility of Gushuling Granules on the icariin Content
  391. Effects of the serum of rats administered icariin on the proliferation and differentiation of rat calvarial osteoblasts in vitro
  392. Effects of the serum of rats administered icariin on the proliferation and osteogenic differentiation of rBMSCs in vitro [J]
  393. Effects of Total Flavonoids of Drynaria fortunei Combined with icariin on Proliferation and Alkaline Phosphatase Activity of Human Periodontal Ligament Cells
  394. Efficient bioconversion of epimedin C to icariin by a glycosidase from Aspergillus nidulans
  395. Electrochemical determination of mangiferin and icariin based on Au-AgNPs/MWNTs-SGSs modified glassy carbon electrode
  396. ENHANCEMENT OF WATER-EXTRACTION PROCESS OF icariin FROM EPIMEDII HERBA BY MICROWAVE TECHNOLOGY
  397. Epimedium koreanum extract and its constituent icariin improve motor dysfunction in spinal cord injury
  398. Epimedium koreanum Nakai and its main constituent icariin suppress lipid accumulation during adipocyte differentiation of 3T3-L1 preadipocytes
  399. Eradication of Propionibacterium acnes biofilms by plant extracts and putative identification of icariin, resveratrol and salidroside as active compounds
  400. Erectogenic and Neurotrophic Effects of icariin, a Purified Extract of Horny Goat Weed (Epimedium spp.) In Vitro and In Vivo
  401. Estrogenic Activities of icariin and Its Possible Metabolitesin Vitro [J]
  402. Estrogenic effect of Herba Epimedii and monosomic icariin in mice
  403. Estrogenic effects of two derivatives of icariin on human breast cancer MCF-7 cells
  404. Evaluation of Measurement Uncertainty for the Determination of the icariin in Compound Eucommia Bark Oral Liquid by HPLC [J]
  405. Evaluation of osteogenesis and angiogenesis of icariin in local controlled release and systemic delivery for calvarial defect in ovariectomized rats
  406. Evaluation of osteogenesis and angiogenesis of icariin loaded on micro/nano hybrid structured hydroxyapatite granules as a local drug delivery system for femoral …
  407. Evaluation of synergistic osteogenesis between icariin and BMP2 through a micro/meso hierarchical porous delivery system
  408. Experimental studies of icariin on anticancer mechanism
  409. Experimental Studies of icariin on Anticancer Mechanism [J]
  410. Experimental study of biologically active icariin combined with a porous PLGA/TCP scaffold to repair cartilage and subchondral bone in articular cartilage defect …
  411. Experimental study of icariin in inducing bone marrow mesenchymal stem cell differentiation
  412. Experimental Study on icariin and β-phosphoric Acid Three Calcium Compound in Repairing Bone Defects [J]
  413. Experimental study on the mechanism of icariin improving human osteoblasts proliferation and the expression of OPG protein
  414. Exploration of icariin analog structure space reveals key features driving potent inhibition of human phosphodiesterase-5
  415. Expression Study of icariin on Function and RLF mRNA Expression in the Rat Ovaries
  416. Extraction Process of icariin in Epimedium brevicornu Maxim.
  417. Facile preparation of biphasic-induced magnetic icariin-loaded composite microcapsules by automated in situ click technology
  418. Flavonoid compound icariin activates hypoxia inducible factor-1α in chondrocytes and promotes articular cartilage repair
  419. Flavonoid compound icariin enhances BMP-2 induced differentiation and signalling by targeting to connective tissue growth factor (CTGF) in SAMP6 …
  420. Flavonoids, apigenin and icariin exert potent melanogenic activities in murine B16 melanoma cells
  421. Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling
  422. Glucocorticoid-induced leucine zipper may play an important role in icariin by suppressing osteogenesis inhibition induced by glucocorticoids in osteoblasts
  423. Glutaraldehyde‐crosslinked chitosan/hydroxyapatite bone repair scaffold and its application as drug carrier for icariin
  424. GW27-e1241 Sex hormone-like protective effects of icariin on regulation of hypertension in SHR
  425. HPLC analysis and pharmacokinetics of icariin in rats
  426. HPLC determination icariin, vitamin B_1 and vitamin B_6 in Gengnianling tablets
  427. HPLC Determination of Content of icariin in Baji Capsule [J]
  428. HPLC determination of icariin content in Zhuanggu Zhitong granule.
  429. HPLC Determination of icariin in Bushen Qiangshen Tablets [J]
  430. HPLC Determination of the Content of the Kidney Progesterone Capsule icariin
  431. HPLC method of controlling quality for icariin in Zhuanggu Guanjie Pill [J]
  432. HPLC simultaneous determination of epimedin B, epimedin C and icariin in Xianlinggubao capsules
  433. Human Safety and Pharmacokinetics Study of Orally Administered icariin: Randomized, Double-Blind, Placebo-Controlled Trial
  434. icariin abrogates osteoclast formation through the regulation of the RANKL-mediated TRAF6/NF-κB/ERK signaling pathway in Raw264. 7 cells
  435. icariin activates autophagy via down-regulation of the NF-κB signaling-mediated apoptosis in chondrocytes
  436. icariin acts as a potential agent for preventing cardiac ischemia/reperfusion injury
  437. icariin administration is associated with enhanced homing of bone marrow-derived progenitor cells, increased levels of CXCR-4/SDF-1 alpha homing factors …
  438. icariin alleviates hypoxia‐induced damage in MC3T3‐E1 cells by down‐regulating TALNEC2
  439. icariin Alleviates IL-1β-Induced Matrix Degradation By Activating The Nrf2/ARE Pathway In Human Chondrocytes
  440. icariin alleviates lipid peroxidation after spinal cord injury in rats
  441. icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome
  442. icariin alleviates osteoarthritis by inhibiting NLRP3-mediated pyroptosis
  443. icariin alleviates varicocele-induced damage to the structure and function of rat epididymis
  444. icariin alters the expression of glucocorticoid receptor, FKBP5 and SGK1 in rat brains following exposure to chronic mild stress
  445. icariin ameliorate thiram-induced tibial dyschondroplasia via regulation of WNT4 and VEGF expression in broiler chickens
  446. icariin Ameliorates Amyloid Pathologies by Maintaining Homeostasis of Autophagic Systems in Aβ1–42-Injected Rats
  447. icariin ameliorates angiotensin II-induced cerebrovascular remodeling by inhibiting Nox2-containing NADPH oxidase activation
  448. icariin ameliorates cigarette smoke induced inflammatory responses via suppression of NF-κB and modulation of GR in vivo and in vitro
  449. icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway
  450. icariin ameliorates dexamethasone‑induced bone deterioration in an experimental mouse model via activation of microRNA‑186 inhibition of cathepsin K
  451. icariin ameliorates IgA nephropathy by inhibition of nuclear factor kappa b/Nlrp3 pathway
  452. icariin ameliorates learning and memory function via improving cerebral glucose metabolism disorder in APP/PS1/Tau triple transgenic Alzheimer’s disease mice
  453. icariin ameliorates learning and memory impairments through ERK/CaMKIIα/CREB signaling and HPA axis in prenatally stressed female offspring
  454. icariin ameliorates neuropathological changes, TGF-β1 accumulation and behavioral deficits in a mouse model of cerebral amyloidosis
  455. icariin ameliorates palmitate-induced insulin resistance through reducing thioredoxin-interacting protein (TXNIP) and suppressing ER stress in C2C12 myotubes
  456. icariin ameliorates spatial learning and memory impairments through upregulating the expressions of PPARα and PGC-1α protein in chronic cerebral hypoperfusion …
  457. icariin ameliorates streptozotocin-induced diabetic retinopathy in vitro and in vivo
  458. icariin-differential-protein-expression-entorhinal/2/01300535″ target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://insights.ovid.com/neural-regeneration-research/nrgr/2011/06/020/icariin-differential-protein-expression-entorhinal/2/01300535&source=gmail&ust=1579280816303000&usg=AFQjCNEdY0Ywpnji-zkT8lKR7-k4XGthgw”>icariin and differential protein expression in the entorhinal area of senescence-accelerated mouse prone 8 mice☆
  459. icariin and icaritin ameliorated hippocampus neuroinflammation via inhibiting HMGB1-related pro-inflammatory signals in lipopolysaccharide-induced inflammation …
  460. icariin and icaritin ameliorated hippocampus neuroinflammation via mediating HMGB1 expression in social defeat model in mice
  461. icariin and icaritin recover UVB-induced photoaging by stimulating Nrf2/ARE and reducing AP-1 and NF-κB signaling pathways: a comparative study on UVB …
  462. icariin and icaritin stimulate the proliferation of SKBr3 cells through the GPER1-mediated modulation of the EGFR-MAPK signaling pathway
  463. icariin and its derivative icariside II extend healthspan via insulin/IGF-1 pathway in C. elegans
  464. icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions
  465. icariin_and_its_emerging_role_in_the_treatment_of.41.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/cmj/Fulltext/2013/01200/icariin_and_its_emerging_role_in_the_treatment_of.41.aspx&source=gmail&ust=1579280816303000&usg=AFQjCNFIFH1ewFJaPUNoo6G4CkVZ45rEvQ”>icariin and its emerging role in the treatment of osteoporosis
  466. icariin and its metabolites as potential protective phytochemicals against Alzheimer’s disease
  467. icariin and its pharmaceutical efficacy: research progress of molecular mechanism
  468. icariin and its phosphorylated derivatives alleviate intestinal epithelial barrier disruption caused by enterotoxigenic Escherichia coli through modulate p38 MAPK in …
  469. icariin and mesenchymal stem cells synergistically promote angiogenesis and neurogenesis after cerebral ischemia via PI3K and ERK1/2 pathways
  470. icariin as a preservative to maintain the fruit quality of banana during postharvest storage
  471. icariin_associated_with_exercise_therapy_is_an.18.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/cmj/Fulltext/2012/05020/icariin_associated_with_exercise_therapy_is_an.18.aspx&source=gmail&ust=1579280816303000&usg=AFQjCNG85cRkEaVpRJ1FpiBW1XzHqmrEgQ”>icariin associated with exercise therapy is an effective treatment for postmenopausal osteoporosis
  472. icariin attenuate microcystin-LR-induced gap junction injury in Sertoli cells through suppression of Akt pathways
  473. icariin attenuated oxidative stress induced-cardiac apoptosis by mitochondria protection and ERK activation
  474. icariin attenuates angiotensin II‑induced hypertrophy and apoptosis in H9c2 cardiomyocytes by inhibiting reactive oxygen species‑dependent JNK and p38 …
  475. icariin attenuates carbon black-induced pulmonary inflammatory response and oxidative stress in mice
  476. icariin attenuates cardiac remodelling through down‐regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure
  477. icariin attenuates cerebral ischemia–reperfusion injury through inhibition of inflammatory response mediated by NF-κB, PPARα and PPARγ in rats
  478. icariin attenuates chronic mild stress-induced dysregulation of the LHPA stress circuit in rats
  479. icariin attenuates glucocorticoid insensitivity mediated by repeated psychosocial stress on an ovalbumin-induced murine model of asthma
  480. icariin attenuates glucocorticoid-induced bone deteriorations, hypocalcemia and hypercalciuria in mice
  481. icariin Attenuates High Glucose-Induced Apoptosis, Oxidative Stress, and Inflammation in Human Umbilical Venous Endothelial Cells
  482. icariin attenuates high glucose‐induced type IV collagen and fibronectin accumulation in glomerular mesangial cells by inhibiting transforming growth factor‐β …
  483. icariin attenuates high-cholesterol diet induced atherosclerosis in rats by inhibition of inflammatory response and p38 MAPK signaling pathway
  484. icariin attenuates hypoxia‐induced oxidative stress and apoptosis in osteoblasts and preserves their osteogenic differentiation potential in vitro
  485. icariin attenuates interleukin-1β-induced inflammatory response in human nucleus pulposus cells
  486. icariin attenuates isoproterenol-induced cardiac toxicity in Wistar rats via modulating cGMP level and NF-κB signaling cascade
  487. icariin attenuates left ventricular remodeling in SHR by up-regulating PPARαand PPARγ
  488. icariin attenuates lipopolysaccharide-induced microglial activation and resultant death of neurons by inhibiting TAK1/IKK/NF-κB and JNK/p38 MAPK pathways
  489. icariin attenuates LPS-induced acute inflammatory responses: Involvement of PI3K/Akt and NF-κB signaling pathway
  490. icariin Attenuates M1 Activation of Microglia and Aβ Plaque Accumulation in the Hippocampus and Prefrontal Cortex by Up-regulating PPARγ in Restraint/isolation …
  491. icariin attenuates methotrexate chemotherapy‐induced bone marrow microvascular damage and bone loss in rats
  492. icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner
  493. icariin attenuates OGD/R-induced autophagy via Bcl-2-dependent cross talk between apoptosis and autophagy in PC12 cells
  494. icariin attenuates renal interstitial fibrosis by reducing aldosterone in SHR
  495. icariin attenuates social defeat-induced down-regulation of glucocorticoid receptor in mice
  496. icariin Attenuates Synaptic and Cognitive Deficits in an Aβ1–42-Induced Rat Model of Alzheimer’s Disease
  497. icariin attenuates the enhanced prothrombotic state in atherosclerotic rabbits independently of its lipid-lowering effects
  498. icariin attenuates the severity of cerulein‑induced acute pancreatitis by inhibiting p38 activation in mice
  499. icariin attenuates titanium particle‐induced inhibition of osteogenic differentiation and matrix mineralization via miR‐21‐5p
  500. icariin attenuates titanium-particle inhibition of bone formation by activating the Wnt/β-catenin signaling pathway in vivo and in vitro
  501. icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells
  502. icariin augments bone formation and reverses the phenotypes of osteoprotegerin-deficient mice through the activation of Wnt/β-catenin-BMP signaling
  503. icariin changes ANGPTL3 expression and LPL activity to improve meat quality in swine
  504. icariin combined with breviscapine improves the erectile function of spontaneously hypertensive rats
  505. icariin combined with human umbilical cord mesenchymal stem cells significantly improve the impaired kidney function in chronic renal failure
  506. icariin combined with snailase shows improved intestinal hydrolysis and absorption in osteoporosis rats
  507. icariin conjugated hyaluronic acid/collagen hydrogel for osteochondral interface restoration
  508. icariin%20decreases%20both%20APP%20and%20A%CE%B2%20levels%20and%20increases%20neurogenesis%20in%20the%20brain%20of%20Tg2576%20mice.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=http://www.tahomaclinic.com/Private/Articles3/Neurogenesis/Li%25202015%2520-%2520icariin%2520decreases%2520both%2520APP%2520and%2520A%25CE%25B2%2520levels%2520and%2520increases%2520neurogenesis%2520in%2520the%2520brain%2520of%2520Tg2576%2520mice.pdf&source=gmail&ust=1579280816304000&usg=AFQjCNGx1VrfDnjtsA8mkGwR5ch9OEOpaw”>icariin decreases both APP and Aβ levels and increases neurogenesis in the brain
  509. icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice
  510. icariin decreases the expression of APP and BACE-1 and reduces the β-amyloid burden in an APP transgenic mouse model of Alzheimer’s disease
  511. icariin delays brain aging in senescence-accelerated mouse prone 8 (SAMP8) model via inhibiting autophagy
  512. icariin delays homocysteine-induced endothelial cellular senescence involving activation of the PI3K/AKT-eNOS signaling pathway
  513. icariin delivery porous PHBV scaffolds for promoting osteoblast expansion in vitro
  514. icariin derivative inhibits inflammation through suppression of p38 mitogen-activated protein kinase and nuclear factor-κB pathways
  515. icariin displays anticancer activity against human esophageal cancer cells via regulating endoplasmic reticulum stress-mediated apoptotic signaling
  516. icariin doped bioactive glasses seeded with rat adipose-derived stem cells to promote bone repair via enhanced osteogenic and angiogenic activities
  517. icariin enhances bone repair in rabbits with bone infection during post-infection treatment and prevents inhibition of osteoblasts by vancomycin
  518. icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway
  519. icariin enhances differentiation and maturation of rat calvarial osteoblasts in collagen hydrogel three-dimensional culture
  520. icariin enhances endothelial nitric-oxide synthase expression on human endothelial cells in vitro
  521. icariin enhances intestinal barrier function by inhibiting NF-κB signaling pathways and modulating gut microbiota in a piglet model
  522. icariin enhances neuronal survival after oxygen and glucose deprivation by increasing SIRT1
  523. icariin enhances proliferation and osteogenic differentiation of goat bone marrow mesenchymal stem cells*,☆
  524. icariin enhances radiosensitivity of colorectal cancer cells by suppressing NF-κB activity
  525. icariin enhances remyelination process after acute demyelination induced by cuprizone exposure
  526. icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway
  527. icariin enhances the healing of rapid palatal expansion induced root resorption in rats
  528. icariin enhances the osteogenic differentiation of bone marrow stromal cells but has no effects on the differentiation of newborn calvarial osteoblasts of rats
  529. icariin enhances the proliferation and expression of osteoprotegerin of human periodontal ligament cells in vitro [J]
  530. icariin enhances the proliferation of human gingival fibroblasts in vitro [J]
  531. icariin exerts a protective effect against d-galactose induced premature ovarian failure via promoting DNA damage repair
  532. icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal …
  533. icariin exerts anabolic effects on osteoblasts via rapid estrogen receptor α signaling pathways
  534. icariin exerts estrogen-like activity in ameliorating EAE via mediating estrogen receptor β, modulating HPA function and glucocorticoid receptor expression
  535. icariin exerts inhibitory effects on the growth and metastasis of KYSE70 human esophageal carcinoma cells via PI3K/AKT and STAT3 pathways
  536. icariin exerts protective effect against myocardial ischemia/reperfusion injury in rats
  537. icariin exterts negative effects on human gastric cancer cell invasion and migration by vasodilator-stimulated phosphoprotein via Rac1 pathway
  538. icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats
  539. icariin from Epimedium brevicornum Maxim promotes the biosynthesis of estrogen by aromatase (CYP19)
  540. icariin has synergistic effects with methylprednisolone to ameliorate EAE via modulating HPA function, promoting anti-inflammatory and anti-apoptotic effects
  541. icariin immobilized electrospinning poly (l-lactide) fibrous membranes via polydopamine adhesive coating with enhanced cytocompatibility and osteogenic activity
  542. icariin impacts molecular changes in estrogen receptors but not other reproductive parameters in female mice
  543. icariin improves acute kidney injury and proteinuria in a rat model of pregnancy‑induced hypertension
  544. icariin improves cognitive deficits and activates quiescent neural stem cells in aging rats
  545. icariin improves cognitive impairment after traumatic brain injury by enhancing hippocampal acetylation
  546. icariin improves eNOS/NO pathway to prohibit the atherogenesis of apolipoprotein E-null mice
  547. icariin improves Fanconi anemia hematopoietic stem cell function through SIRT6-mediated NF-kappa B inhibition
  548. icariin Improves Functional Behavior in a Mouse Model of Traumatic Brain Injury and Promotes Synaptic Plasticity Markers
  549. icariin improves learning and memory via promoting angiogenesis in bilateral common carotid artery occlusion rats
  550. icariin improves memory impairment in Alzheimer’s disease model mice (5xFAD) and attenuates amyloid β‐induced neurite atrophy
  551. icariin improves osteoporosis, inhibits the expression of PPARγ, C/EBPα, FABP4 mRNA, N1ICD and jagged1 proteins, and increases Notch2 mRNA in …
  552. icariin Improves Sepsis-Induced Mortality and Acute Kidney Injury
  553. icariin improves SHR erectile function via inhibiting eNOS uncoupling
  554. icariin improves the cognitive function of APP/PS1 mice via suppressing endoplasmic reticulum stress
  555. icariin improves the cognitive function of APP/PS1 mice via suppressing ER stress
  556. icariin improves the sexual function of male mice through the PI 3K/AKT/eNOS/NO signalling pathway
  557. icariin improves the viability and function of cryopreserved human nucleus pulposus-derived mesenchymal stem cells
  558. icariin increases chondrocyte vitality by promoting hypoxia-inducible factor-1α expression and anaerobic glycolysis
  559. icariin Induced B16 Melanoma Tumor Cells Apoptosis, Suppressed Tumor Growth and Metastasis.
  560. icariin induced proliferation and differentiation of MC3T3-E1 osteoblasts via ERK and JNK signaling coupled with estrogen receptor
  561. icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7/TAM
  562. icariin induces apoptosis in acute promyelocytic leukemia by targeting PIM1
  563. icariin induces apoptosis in mouse MLTC-10 Leydig tumor cells through activation of the mitochondrial pathway and down-regulation of the expression of piwil4
  564. icariin induces apoptosis of esophageal cancer cell through enhancing Fas-FasL expression activity
  565. icariin induces apoptosis of human lung adenocarcinoma cells by activating the mitochondrial apoptotic pathway
  566. icariin induces cell differentiation and cell cycle arrest in mouse melanoma B16 cells via Erk1/2-p38-JNK-dependent pathway
  567. icariin induces irisin/FNDC5 expression in C2C12 cells via the AMPK pathway
  568. icariin induces MC3T3-E1 cell proliferation and differentiation via the BMP-2/Smads/Runx2 signal pathway
  569. icariin induces mouse embryonic stem cell differentiation into beating functional cardiomyocytes
  570. icariin induces osteoblast differentiation and mineralization without dexamethasone in vitro
  571. icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation
  572. icariin induces osteogenic differentiation in vitro in a BMP-and Runx2-dependent manner
  573. icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK‐dependent manner
  574. icariin induces S-phase arrest and apoptosis in medulloblastoma cells
  575. icariin induces synoviolin expression through NFE2L1 to protect neurons from ER stress-induced apoptosis
  576. icariin induces the expression of toll‐like receptor 9 in ana‐1 murine macrophages
  577. icariin induces the growth, migration and osteoblastic differentiation of human periodontal ligament fibroblasts by inhibiting Toll-like receptor 4 and NF-κB p65 …
  578. icariin inducing the differentiation of MC3 T3-E1 Subclone14 cells via estrogen receptor and p 38MAPK signaling pathway in vitro
  579. icariin inducting MC3T3-E1 cell proliferation and differentiation with the activation of BMP-2 intracellular signal pathway
  580. icariin influences adipogenic differentiation of stem cells affected by osteoblast-osteoclast co-culture and clinical research adipogenic
  581. icariin influences cardiac remodeling following myocardial infarction by regulating the CD147/MMP-9 pathway
  582. icariin Inhibits AGE-Induced Injury in PC12 Cells by Directly Targeting Apoptosis Regulator Bax
  583. icariin inhibits AMPK-dependent autophagy and adipogenesis in adipocytes In Vitro and in a model of graves’ orbitopathy In Vivo
  584. icariin inhibits atherosclerosis progress in Apoe null mice by downregulating CX3CR1 in macrophage
  585. icariin inhibits autophagy and promotes apoptosis in SKVCR cells through mTOR signal pathway.
  586. icariin inhibits beta-amyloid peptide segment 25–35 induced expression of β-secretase in rat hippocampus
  587. icariin inhibits cell proliferation, migration and invasion by down-regulation of microRNA-625-3p in thyroid cancer cells
  588. icariin inhibits chondrocyte apoptosis and angiogenesis by regulating the TDP‐43 signaling pathway
  589. icariin inhibits corticosterone-induced apoptosis in hypothalamic neurons via the PI3-K/Akt signaling pathway
  590. icariin Inhibits Endoplasmic Reticulum Stress-induced Neuronal Apoptosis After Spinal Cord
  591. icariin inhibits endoplasmic reticulum stress-induced neuronal apoptosis after spinal cord injury through modulating the PI3K/AKT signaling pathway
  592. icariin Inhibits Foam Cell Formation by Down‐Regulating the Expression of CD36 and Up‐Regulating the Expression of SR‐BI
  593. icariin inhibits growth of human osteosarcoma cells by inducing apoptosis via downregulation of β-catenin signaling
  594. icariin inhibits hydrogen peroxide-induced toxicity through inhibition of phosphorylation of JNK/p38 MAPK and p53 activity
  595. icariin Inhibits Hydrogen Peroxide‐Mediated Cytotoxicity by Up‐regulating Sirtuin Type 1‐Dependent Catalase and Peroxiredoxin
  596. icariin inhibits inflammation via immunomodulation of the cutaneous hypothalamus–pituitary–adrenal axis in vitro
  597. icariin inhibits LPS-induced cell inflammatory response by promoting GRα nuclear translocation and upregulating GRα expression
  598. icariin inhibits MMP‑1, MMP‑3 and MMP‑13 expression through MAPK pathways in IL‑1β‑stimulated SW1353 chondrosarcoma cells
  599. icariin_inhibits_neurotoxicity_of___amyloid_by.12.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/neuroreport/Fulltext/2009/11250/icariin_inhibits_neurotoxicity_of___amyloid_by.12.aspx&source=gmail&ust=1579280816305000&usg=AFQjCNG5LhhogskpuM4OBK03C7g-Z75qRw”>icariin inhibits neurotoxicity of β-amyloid by upregulating cocaine-regulated and amphetamine-regulated transcripts
  600. icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE2 synthesis
  601. icariin inhibits oxidized low-density lipoprotein-induced proliferation of vascular smooth muscle cells by suppressing activation of extracellular signal …
  602. icariin inhibits pulmonary hypertension induced by monocrotaline through enhancement of NO/cGMP signaling pathway in rats
  603. icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-κB and MAPK signaling pathways
  604. icariin inhibits the apoptosis of cemx174 triggered by simian immuno deficiency virus infection in vitro
  605. icariin inhibits the growth of human cervical cancer cells by inducing apoptosis and autophagy by targeting mTOR/PI3K/AKT signalling pathway
  606. icariin Inhibits the Increased Inward Calcium Currents Induced by Amyloid-β25-35 Peptide in CA1 Pyramidal Neurons of Neonatal Rat Hippocampal Slice
  607. icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture
  608. icariin inhibits titanium particle-induced inflammatory reaction
  609. icariin inhibits TNF-α/IFN-γ induced inflammatory response via inhibition of the substance P and p38-MAPK signaling pathway in human keratinocytes
  610. icariin intervenes in cardiac inflammaging through upregulation of SIRT6 enzyme activity and inhibition of the NF-kappa B pathway
  611. icariin intervenes wear particles-induced osteolysis
  612. icariin is a PPARα activator inducing lipid metabolic gene expression in mice
  613. icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro
  614. icariin isolated from Epimedium brevicornum Maxim attenuates learning and memory deficits induced by d-galactose in rats
  615. icariin isolated from Epimedium pubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfa1 expression
  616. icariin loaded-hollow bioglass/chitosan therapeutic scaffolds promote osteogenic differentiation and bone regeneration
  617. icariin may benefit the mesenchymal stem cells of patients with steroid-associated osteonecrosis by ABCB1-promoter demethylation: a preliminary study
  618. icariin metabolism by human intestinal microflora
  619. icariin mitigate learning and memory decrease and enhancement active of Na~+-K~+-ATPase, Ca~(2+)-ATPase by aluminum in rats
  620. icariin modulates carrageenan-induced acute inflammation through HO-1/Nrf2 and NF-kB signaling pathways
  621. icariin modulates mitochondrial function and apoptosis in high glucose-induced glomerular podocytes through G protein-coupled estrogen receptors
  622. icariin on relaxation effect of corpus cavernosum smooth muscle
  623. icariin possesses chondroprotective efficacy in a rat model of dexamethasone-induced cartilage injury through the activation of miR-206 targeting of cathepsin …
  624. icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB
  625. icariin prevents amyloid beta-induced apoptosis via the PI3K/Akt pathway in PC-12 cells
  626. icariin prevents bone loss by inhibiting bone resorption and stabilizing bone biological apatite in a hindlimb suspension rodent model
  627. icariin Prevents Bone Loss through Facilitating the Stabilization of Bone Biological Apatite in Hindlimb Suspension Rats
  628. icariin prevents cartilage and bone degradation in experimental models of arthritis
  629. icariin prevents cytokine‑induced β‑cell death by inhibiting NF‑κB signaling
  630. icariin Prevents Diabetes-Induced Bone Loss in Rats by Reducing Blood Glucose and Suppressing Bone Turnover
  631. icariin prevents H2O2-induced apoptosis via the PI3K/Akt pathway in rat nucleus pulposus intervertebral disc cells
  632. icariin prevents hypertension-induced cardiomyocyte apoptosis through the mitochondrial apoptotic pathway
  633. icariin prevents IL-1β-induced apoptosis in human nucleus pulposus via the PI3K/AKT pathway
  634. icariin_prevents_ovariectomy_induced_bone_loss_and.16.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/menopausejournal/Fulltext/2014/09000/icariin_prevents_ovariectomy_induced_bone_loss_and.16.aspx&source=gmail&ust=1579280816306000&usg=AFQjCNFAd2on-QTWwwEWR8rEi-l4FQpA1A”>icariin prevents ovariectomy-induced bone loss and lowers marrow adipogenesis
  635. icariin promote chondrocytes cultured on 3-D condition to generate new Cartilage in vitro
  636. icariin promote maturation of osteoblasts in vitro by an estrogen-independent mechanism
  637. icariin promoted osteogenic differentiation of SD rat bone marrow mesenchymal stem cells: an experimental study
  638. icariin promotes angiogenesis in glucocorticoid‐induced osteonecrosis of femoral heads: In vitro and in vivo studies
  639. icariin promotes angiogenic differentiation and prevents oxidative stress‐induced autophagy in endothelial progenitor cells
  640. icariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway in the hFOB 1.19 human osteoblastic cell line
  641. icariin promotes cell proliferation and regulates gene expression in human neural stem cells in vitro
  642. icariin promotes differentiation and maturation of cord blood-derived dendritic cells.
  643. icariin promotes directed chondrogenic differentiation of bone marrow mesenchymal stem cells but not hypertrophy in vitro
  644. icariin promotes early and late stages of fracture healing in rats
  645. icariin promotes early and late stages of fracture healing in rats.
  646. icariin promotes expression of junctophilin 2 and Ca2+ related function during cardiomyocyte differentiation of murine embryonic stem cells
  647. icariin-promotes-expression-pgc-ppar-nrf-during/4/00145742″ target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://insights.ovid.com/acta-pharmacologica-sinica/aphsa/2007/10/000/icariin-promotes-expression-pgc-ppar-nrf-during/4/00145742&source=gmail&ust=1579280816306000&usg=AFQjCNEwVzWo6uI9Qda8E9YG3_I6Pl2acw”>icariin promotes expression of PGC-1α, PPARα, and NRF-1 during cardiomyocyte differentiation of murine embryonic stem cells in vitro1
  648. icariin promotes expression of PGC‐1α, PPARα, and NRF‐1 during cardiomyocyte differentiation of murine embryonic stem cells in vitro1
  649. icariin Promotes Extracellular Matrix Synthesis and Gene Expression of Chondrocytes In Vitro
  650. icariin promotes histone acetylation and attenuates post-stroke cognitive impairment in the central cholinergic circuits of mice
  651. icariin Promotes More Rat Marrow Stromal Cell Osteogenic Differentiation Than Osthole [J]
  652. icariin promotes mouse hair follicle growth by increasing insulin‐like growth factor 1 expression in dermal papillary cells
  653. icariin promotes osteoblast differentiation and inhibits adipogenesis of bone marrow stem cells through activation of Wnt/β-catenin signaling in vivo and in vitro
  654. icariin promotes osteoblastic differentiation in OVX mice via MAPK signaling pathway revealed by profiling
  655. icariin promotes osteogenic differentiation by suppressing Notch signaling
  656. icariin promotes osteogenic differentiation of bone marrow mesenchymal stem cells
  657. icariin promotes osteogenic differentiation of bone marrow stromal cells and prevents bone loss in OVX mice via activating autophagy
  658. icariin promotes osteogenic differentiation of rat bone marrow stromal cells by activating the ERα-Wnt/β-catenin signaling pathway
  659. icariin promotes osteogenic differentiation of rat bone marrow stromal cells in vitro
  660. icariin promotes proliferation and osteogenic differentiation of rat adipose-derived stem cells by activating the RhoA-TAZ signaling pathway
  661. icariin promotes self-renewal of neural stem cells: an involvement of extracellular regulated kinase signaling pathway
  662. icariin promotes stable chondrogenic differentiation of bone marrow mesenchymal stem cells in self‑assembling peptide nanofiber hydrogel scaffolds
  663. icariin promotes tendon-bone healing during repair of rotator cuff tears: a biomechanical and histological study
  664. icariin promotes the migration of BMSCs in vitro and in vivo via the MAPK signaling pathway
  665. icariin promotes the migration of bone marrow stromal cells via the sDF-1α/hiF-1α/cXcr4 pathway
  666. icariin Promotes the Osteogenic Action of BMP2 by Activating the cAMP Signaling Pathway
  667. icariin promotes the proliferation and differentiation of osteoblasts from the rat mandible by the Wnt/β‑catenin signalling pathway
  668. icariin promotes the proliferation of human periosteum cells and the underlying mechanism
  669. icariin promotes wound healing by enhancing the migration and proliferation of keratinocytes via the AKT and ERK signaling pathway
  670. icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor‐dependent osteoblastic functions in UMR 106 cells
  671. icariin protects against brain injury by enhancing SIRT1-dependent PGC-1α expression in experimental stroke
  672. icariin protects against cerebral ischemia/reperfusion injury by activating the PI3K/Akt signaling pathway
  673. icariin protects against cyclophosphamide-induced obstacle of mouse bone marrow mesenchymal stem cells differentiating into osteoblasts
  674. icariin protects against glucocorticoid induced osteoporosis, increases the expression of the bone enhancer DEC1 and modulates the PI3K/Akt/GSK3β/β-catenin …
  675. icariin protects against glucocorticoid-induced osteonecrosis of the femoral head in rats
  676. icariin protects against glucocorticoid-induced osteoporosis in vitro and prevents glucocorticoid-induced osteocyte apoptosis in vivo
  677. icariin protects against intestinal ischemia–reperfusion injury
  678. icariin protects against iron overload‐induced bone loss via suppressing oxidative stress
  679. icariin protects against ischemia‑reperfusion injury in H9C2 cells by upregulating heat shock protein 20
  680. icariin protects against MPP+-induced neurotoxicity in MES23. 5 cells.
  681. icariin protects against radiation-induced mortality and damage in vitro and in vivo
  682. icariin protects against thioacetamide-induced liver fibrosis in rats: Implication of anti-angiogenic and anti-autophagic properties
  683. icariin protects against titanium particle-induced osteolysis and inflammatory response in a mouse calvarial model
  684. icariin protects bone marrow mesenchymal stem cells against iron overload induced dysfunction through mitochondrial fusion and fission, PI3K/AKT/mTOR and MAPK …
  685. icariin protects cardiomyocytes against ischaemia/reperfusion injury by attenuating sirtuin 1‐dependent mitochondrial oxidative damage
  686. icariin protects H9c2 cardiomyocytes from lipopolysaccharide‑induced injury via inhibition of the reactive oxygen species‑dependent c‑Jun N‑terminal kinases …
  687. icariin protects human nucleus pulposus cells from hydrogen peroxide-induced mitochondria-mediated apoptosis by activating nuclear factor erythroid 2-related factor …
  688. icariin protects mouse Leydig cell testosterone synthesis from the adverse effects of di (2-ethylhexyl) phthalate
  689. icariin protects murine chondrocytes from lipopolysaccharide-induced inflammatory responses and extracellular matrix degradation
  690. icariin protects rat cardiac H9c2 cells from apoptosis by inhibiting endoplasmic reticulum stress
  691. icariin protects rats against 5/6 nephrectomy-induced chronic kidney failure by increasing the number of renal stem cells
  692. icariin protects rotenone-induced neurotoxicity through induction of SIRT3
  693. icariin protects SH-SY5Y cells from formaldehyde-induced injury through suppression of Tau phosphorylation
  694. icariin protects vascular endothelial cells from oxidative stress through inhibiting endoplasmic reticulum stress
  695. icariin recovers the osteogenic differentiation and bone formation of bone marrow stromal cells from a rat model of estrogen deficiency-induced osteoporosis
  696. icariin reduces bone loss in a Rankl‐induced transgenic medaka (Oryzias latipes) model for osteoporosis
  697. icariin Reduces Cartilage Degeneration in a Mouse Model of Osteoarthritis and is Associated with the Changes in Expression of Indian Hedgehog and …
  698. icariin reduces dopaminergic neuronal loss and microglia-mediated inflammation in vivo and in vitro
  699. icariin reduces high glucose‑induced endothelial progenitor cell dysfunction via inhibiting the p38/CREB pathway and activating the Akt/eNOS/NO pathway
  700. icariin reduces human colon carcinoma cell growth and metastasis by enhancing p53 activities
  701. icariin reduces mitochondrial oxidative stress injury in diabetic rat hearts
  702. icariin reduces S-nitrosogultathione induced endothelial cell apoptosis through modulating AKT/P53 pathway
  703. icariin reduces α-synuclein over-expression by promoting α-synuclein degradation
  704. icariin regulates cellular functions and gene expression of osteoarthritis patient-derived human fibroblast-like synoviocytes
  705. icariin Regulates Expression of Cytokines in Osteoblasts [J]
  706. icariin regulates PRMT/ADMA/DDAH pathway to improve endothelial function
  707. icariin regulates systemic iron metabolism by increasing hepatic hepcidin expression through Stat3 and Smad1/5/8 signaling
  708. icariin regulates the bidirectional differentiation of bone marrow mesenchymal stem cells through canonical Wnt signaling pathway
  709. icariin regulates the osteoblast differentiation and cell proliferation of MC3T3‑E1 cells through microRNA‑153 by targeting Runt‑related transcription factor 2
  710. icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2
  711. icariin restores bone structure and strength in a rat model of chronic high-dose alcohol-induced osteopenia
  712. icariin reversed metastatic phenotype of methotrexate-resistant lung cancer A549 cells
  713. icariin reversed metastatic phenotype of methotrexate-resistant lung cancer A549 cells [J]
  714. icariin reverses corticosterone-induced depression-like behavior, decrease in hippocampal brain-derived neurotrophic factor (BDNF) and metabolic network …
  715. icariin similar to pyriproxifen act as an juvenile hormone analog on larval metamorphosis of the barnacle, Amphibalanus Amphitrite
  716. icariin stimulates angiogenesis by activating the MEK/ERK-and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells
  717. icariin stimulates differentiation and suppresses adipocytic transdifferentiation of primary osteoblasts through estrogen receptor-mediated pathway
  718. icariin stimulates differentiation of bone marrow-derived mesenchymal stem cells (BM-MSCs) through activation of cAMP/PKA/CREB
  719. icariin stimulates MC3T3-E1 cell proliferation and differentiation through up-regulation of bone morphogenetic protein-2
  720. icariin stimulates osteogenic differentiation and suppresses adipogenic differentiation of rBMSCs via estrogen receptor signaling
  721. icariin stimulates osteogenic differentiation of rat bone marrow stromal stem cells by increasing TAZ expression
  722. icariin stimulates the osteogenic differentiation of rat bone marrow stromal cells via activating the PI3K–AKT–eNOS–NO–cGMP–PKG
  723. icariin stimulates the proliferation of rat bone mesenchymal stem cells via ERK and p38 MAPK signaling
  724. icariin stimulates the proliferation of rat Sertoli cells in an ERK1/2‐dependent manner in vitro
  725. icariin supplementation protects mice from exercise-induced oxidant stress in liver
  726. icariin suppresses bone resorption activity of rabbit osteoclasts in vitro
  727. icariin suppresses cell cycle transition and cell migration in ovarian cancer cells
  728. icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma
  729. icariin targets Nrf2 signaling to inhibit microglia-mediated neuroinflammation
  730. icariin Treatment Enhanced the Skeletal Response to Exercise in Estrogen-Deficient Rats
  731. icariin upregulates phosphorylated cyclic adenosine monophosphate response element binding protein levels in the hippocampus of the senescence …
  732. icariin with different concentrations promotes osteogenic differentiation of human bone marrow mesenchymal stem cells
  733. icariin, a flavonoid from the herb Epimedium enhances the osteogenic differentiation of rat primary bone marrow stromal cells
  734. icariin, a flavonoid with anti-cancer effects, alleviated paclitaxel-induced neuropathic pain in a SIRT1-dependent manner
  735. icariin, a major constituent from Epimedium brevicornum, attenuates ibotenic acid-induced excitotoxicity in rat hippocampus
  736. icariin, a major constituent of flavonoids from Epimedium brevicornum, protects against cognitive deficits induced by chronic brain hypoperfusion via its anti …
  737. icariin, a natural flavonol glycoside, extends healthspan in mice
  738. icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway
  739. icariin, a novel blocker of sodium and calcium channels, eliminates early and delayed afterdepolarizations, as well as triggered activity, in rabbit …
  740. icariin, a phoshphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling
  741. icariin, an active ingredient in Herba Epimedii, exerts bone protective effects in vivo and in vitro
  742. icariin, an anti-atherosclerotic drug from chinese medicinal herb horny goat weed
  743. icariin, but not genistein, exerts osteogenic and anti-apoptotic effects in osteoblastic cells by selective activation of non-genomic ERα signaling
  744. icariin: A potential compound for the recovery of tibial dyschondroplasia affected chicken via up-regulating bmp-2 expression
  745. icariin: a potential osteoinductive compound for bone tissue engineering
  746. icariin: a potential promoting compound for cartilage tissue engineering
  747. icariin: A promising osteoinductive compound for repairing bone defect and osteonecrosis
  748. icariin: a special antioxidant to protect linoleic acid against free-radical-induced peroxidation in micelles
  749. icariin: Can an herbal extract enhance dental implant outcomes?
  750. icariin: does it have an osteoinductive potential for bone tissue engineering?
  751. icariin-conditioned serum engineered with hyaluronic acid promote repair of articular cartilage defects in rabbit knees
  752. icariin-Functionalized Coating on TiO2 Nanotubes Surface to Improve Osteoblast Activity In Vitro and Osteogenesis Ability In Vivo
  753. icariin‐induced miR‐875‐5p attenuates epithelial‐mesenchymal transition by targeting hedgehog signaling in liver fibrosis
  754. icariin-loaded electrospun PCL/gelatin nanofiber membrane as potential artificial periosteum
  755. icariin-loaded electrospun PCL/gelatin sub-microfiber mat for preventing epidural adhesions after laminectomy
  756. icariin-Loaded Polyvinyl Alcohol/Agar Hydrogel: Development, Characterization, and In Vivo Evaluation in a Full-Thickness Burn Model
  757. icariin-loaded porous scaffolds for bone regeneration through the regulation of the coupling process of osteogenesis and osteoclastic activity
  758. icariin-Loaded TiO2 Nanotubes for Regulation of the Bioactivity of Bone Marrow Cells
  759. icariin-mediated activation of autophagy confers protective effect on rotenone induced neurotoxicity in vivo and in vitro
  760. icariin-mediated differentiation of mouse adipose-derived stem cells into cardiomyocytes
  761. icariin‐mediated expression of cardiac genes and modulation of nitric oxide signaling pathway during differentiation of mouse embryonic stem cells into …
  762. icariin-mediated inhibition of NF-κB activity enhances the in vitro and in vivo antitumour effect of 5-fluorouracil in colorectal cancer
  763. icariin-mediated modulation of cell cycle and p53 during cardiomyocyte differentiation in embryonic stem cells
  764. icariin-treated human umbilical cord mesenchymal stem cells decrease chronic liver injury in mice
  765. Identification and determination for the icariin in Yannianle Oral Solution [J]
  766. Immunoadjuvant activity of icariin that induces Th1-type antibody in mice
  767. Impaired hypothalamic insulin signaling in CUMS rats: restored by icariin and fluoxetine through inhibiting CRF system
  768. Improved Pharmacokinetics of icariin (ICA) within Formulation of PEG-PLLA/PDLA-PNIPAM Polymeric Micelles
  769. Improvement of kidney yang syndrome by icariin through regulating hypothalamus-pituitary-adrenal axis
  770. In silico insight into potential anti-Alzheimer’s disease mechanisms of icariin
  771. In vivo and in vitro anti-inflammatory effects of a novel derivative of icariin
  772. In Vivo and In Vitro Inhibitory Effects of icariin on Angiogenesis.
  773. In vivo pharmacokinetics comparisons of icariin, emodin and psoralen from gan-kang granules and extracts of herba Epimedii, Nepal dock root, Ficus hirta yahl
  774. Inducible effects of icariin, icaritin, and desmethylicaritin on directional differentiation of embryonic stem cells into cardiomyocytes in vitro
  775. Influence of icariin on Adhesion Molecule Gene Expression in Hyperlipidemia Rats
  776. Influence of processing and storage on contents of icariin and total flavonoids of Epimedii Folium
  777. Influence of temperature on total flavonoids and icariin in fried E. wushanense TS Ying
  778. Influence of Ultrasonic on Biotransformation Effect of icariin.
  779. Inhibition of airway remodeling and inflammatory response by icariin in asthma
  780. Inhibition of Th1/Th17 responses via suppression of STAT1 and STAT3 activation contributes to the amelioration of murine experimental colitis by a natural flavonoid glucoside icariin
  781. Inhibition of β-Amyloid Protein (Aβ_ (25-35))-Induced Neurotoxicity by icariin via Wnt/β-Catenin Signaling Pathway [J]
  782. Inhibitive Effect and Mechanism of icariin on Adhesion and Migration of AGS Cells [J]
  783. Inhibitory effect of icariin on acetylcholinesterase
  784. Inhibitory effect of icariin on expression of myelin inhibitory factors in the central nervous system of rats with focal cerebral ischemia**☆
  785. Inhibitory effect of icariin on osteosarcoma cell proliferation via the Wnt/β-catenin signaling pathway
  786. Inhibitory effect of icariin on Ti-induced inflammatory osteoclastogenesis
  787. Inhibitory effects of icariin on melanogenesis of human epidermal melanocytes
  788. Interaction of the bioactive flavonol, icariin, with the essential human solute carrier transporters
  789. Interactions of icariin and IcarisideⅠ with Bovine Serum Albumin Analyzed by Fluorescence Spectroscopy [J]
  790. Involvement of androgen receptor in nitric oxide production induced by icariin in human umbilical vein endothelial cells
  791. Involvement of NF-κB and AP-1 activation in icariin promoted cardiac differentiation of mouse embryonic stem cells
  792. Involvement of p38MAPK and reactive oxygen species in icariin-induced cardiomyocyte differentiation of murine embryonic stem cells in vitro
  793. Involvement of PIKE in icariin induced cardiomyocyte differentiation from murine embryonic stem cells
  794. Involvement of ubiquitin–proteasome system in icariin‐induced cardiomyocyte differentiation of embryonic stem cells using two‐dimensional gel electrophoresis
  795. LC–MS/MS method for the simultaneous determination of icariin and its major metabolites in rat plasma
  796. LC-MS-MS method for simultaneous determination of icariin and its active metabolite icariside II in human plasma
  797. Light stress suppresses the accumulation of epimedins A, B, C, and icariin in Epimedium, a traditional medicinal plant
  798. Loading icariin on titanium surfaces by phase-transited lysozyme priming and layer-by-layer self-assembly of hyaluronic acid/chitosan to improve surface …
  799. Local administration of icariin contributes to peripheral nerve regeneration and functional recovery
  800. Local icariin application enhanced periodontal tissue regeneration and relieved local inflammation in a minipig model of periodontitis
  801. Local injection of icariin on orthodontically induced inflammatory root resorption in rats
  802. Long-term icariin treatment ameliorates cognitive deficits via CD4+ T cell-mediated immuno-inflammatory responses in APP/PS1 mice
  803. Measurement of the content of icariin in Bushen Zhuanggu Granula by HPLC
  804. Mechanism of Action of icariin in Bone Marrow Mesenchymal Stem Cells
  805. Mechanism research of icariin regulation of bone resorption through OPG/RANKL signal pathway
  806. Mechanisms of icariin in regulating bone formation of osteoblasts and bone resorption of osteoclasts
  807. Membrane Transport of the icariin, which is Main Component of Naoyiyuan Tables Across the Caco-2 Monolayer
  808. Metabolic profiling of icariin in rat feces, urine, bile and plasma after oral administration using ultra-high performance liquid chromatography/quadrupole time-of-flight …
  809. Metabolism profiles of icariin in rats using ultra-high performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry and in vitro …
  810. Metabolite Profiles of icariin in Rat Feces, Bile and Urine by Ultraperformance Liquid-Chromatography/Quadrupole-Time-of-Flight Mass Spectrometry
  811. Metabolite profiles of icariin in rat plasma by ultra-fast liquid chromatography coupled to triple-quadrupole/time-of-flight mass spectrometry
  812. mGluR5 stimulating Homer–PIKE formation initiates icariin induced cardiomyogenesis of mouse embryonic stem cells by activating reactive oxygen species
  813. Microbial metabolism studies of icariin derivatives
  814. Modulating functions of icariin emodin and baicalin on bone resorption caused by osteoclasts in vitro [J]
  815. icariin_on_rat_asthmatic.19.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/cmj/Fulltext/2011/09020/Molecular_mechanism_of_icariin_on_rat_asthmatic.19.aspx&source=gmail&ust=1579280816309000&usg=AFQjCNG038o5jGFpU-gFPe3TCm2uIJgkFQ”>Molecular mechanism of icariin on rat asthmatic model
  816. Molecular mechanism of the combination of mechanical strain stimulation and icariin on inhibiting the differentiation of osteoclasts induced by fatigue load stimulation
  817. Morphological character of growth cycle for Epimedium acuminatim and icariin content analysis
  818. Morphological Observation on Critical-Sized Cranial Defect Repaired by icariin and Autologous Concentrate Growth Factors in Rabbits
  819. mPEG-icariin nanoparticles for treating myocardial ischaemia
  820. Neuroprotective effect of icariin on spinal cord injury in rats
  821. Neuroprotective effects of icariin and astragaloside Ⅳ on corticosterone-induced apoptosis in primary cultured rat hippocampal neurons [J]
  822. Neuroprotective effects of icariin on brain metabolism, mitochondrial functions, and cognition in triple‐transgenic Alzheimer’s disease mice
  823. Neuroprotective effects of icariin on corticosterone-induced apoptosis in primary cultured rat hippocampal neurons
  824. Neuroprotective effects of icariin on memory impairment and neurochemical deficits in senescence-accelerated mouse prone 8 (SAMP8) mice
  825. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson’s disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways
  826. Neuroprotective role of icariin in experimental spinal cord injury via its antioxidant, anti‑neuroinflammatory and anti‑apoptotic properties
  827. New pathway of icariin-induced MSC osteogenesis: transcriptional activation of TAZ/Runx2 by PI3K/Akt
  828. Optimal combination of baicalin, icariin and Astragalus saponin I from a Chinese herbal compound Biminne
  829. Optimization of extraction process of icariin from Epimedium by uniform design [J]
  830. Optimization of icariin and Training Method of Improving Rat’s Exercise Capacity by Orthogonal Design
  831. Optimization of Microwave-assisted Extraction Process for icariin from Epimedium by Response Surface Methodology [J]
  832. Optimization of the Extraction Technology of icariin from Herba Epimedii [J]
  833. Optimization of the process for purifying icariin from Herba Epimedii by macroporous resin and the regulatory role of icariin in the tumor immune …
  834. Optimized biotransformation of icariin into Icariside II by β-Glucosidase from trichoderma viride using central composite design method
  835. Optimizing Preparation Technique of Inclusion Compound of icariin-hydroxypropyl-β-cylodextrin by Orthogonal Methods [J]
  836. Optimum Conditions of Extracting icariin by Microwave Method [J]
  837. Optimum Conditions of Extracting icariin by Ultrasonic Wave Method
  838. Orthogonal study on extracting icariin from Gastrodia elata and Uncaria rhynchophylla formulation
  839. Osteogenic potential of icariin compared with recombinant human bone morphogenetic protein 2 in vitro: a preliminary study
  840. Peripubertal administration of icariin and icaritin advances pubertal development in female rats
  841. Pharmacokinetic Studies on icariin of Naoyiyuan Tablets in Rat Plasma
  842. Pharmacokinetics analysis of icariin in rats coming from Chinese medicine compound recipe and single medicinal materials
  843. Pharmacokinetics and tissue distribution profile of icariin propylene glycol‐liposome intraperitoneal injection in mice
  844. Pharmacokinetics of epimedin A, B, C and icariin of Chuankezhi injection in rat
  845. Pharmacokinetics, tissue distribution, and metabolism study of icariin in rat
  846. Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii
  847. Phosphorylation of icariin can alleviate the oxidative stress caused by the duck hepatitis virus a through mitogen-activated protein kinases signaling pathways
  848. PI3K/Akt signaling pathway is involved in the neuroprotective effects of icariin on dopaminergic neurons in the mice model of Parkinson’s disease
  849. PI3K–AKT Signaling Activation and icariin: The Potential Effects on the Perimenopausal Depression-Like Rat Model
  850. PL 07. icariin for the managment of sexual health concerns in men
  851. Plant polyphenols in the treatment of age‐associated diseases: Revealing the pleiotropic effects of icariin by network analysis
  852. PLGA scaffold carrying icariin to inhibit the progression of osteoarthritis in rabbits
  853. Polystyrene-type uniform porous microsphere enables high resolution and low-pressure chromatography of natural products–a case study with icariin purification
  854. Porous composite scaffold incorporating osteogenic phytomolecule icariin for promoting skeletal regeneration in challenging osteonecrotic bone in rabbits
  855. Potent inhibition of human phosphodiesterase-5 by icariin derivatives
  856. Potent inhibition of human phosphodiesterase-5 by icariin derivatives in an enzyme assay
  857. Potential of icariin metabolites from Epimedium koreanum Nakai as antidiabetic therapeutic agents
  858. Prenylflavonoid icariin induces ERE-independent estrogenic responses in a tissue selective manner
  859. Preparation and biological evaluation of chitosan–collagen–icariin composite scaffolds for neuronal regeneration
  860. Preparation and characterization of a novel hyaluronic acid–icariin conjugate hydrogel
  861. Preparation and characterization of icariin/PHBV drug delivery coatings on anodic oxidized titanium
  862. Preparation and characterization of self-assembly vesicle of icariin nanofiber
  863. Preparation and in vitro release of icariin stealth solid liposomes nanoparticles [J]
  864. Preparation and in vitro release of icariin-loaded chitosan/gelatin microspheres
  865. Preparation of a controlled-release icariin/beta-tricalcium phosphate composite scaffold
  866. Preparation of baohuoside Ⅰ by enzymolysis of icariin with cellulase
  867. Preparation of Different Bases of icariin Ointment and Determination of Drug Releasing Rate [J]
  868. Preparation of icariin and Deferoxamine Functionalized Poly(l-lactide)/chitosan Micro/Nanofibrous Membranes with Synergistic Enhanced Osteogenesis and …
  869. Preparation of icariin/gelatin nanocomposite-PLGA sustained release system and its optimization of technology
  870. Preparation of icariin/TiO2 nanotube composite coating on pure titanium surface and analysis of early drug release.
  871. Preparation of icariin-poly (lactic acid)/hydroxyapatite composite bone-graft substitutes by supercritical carbon dioxide method
  872. Preparation of icariside II from icariin by enzymatic hydrolysis method
  873. Preparation of two derivatives from icariin and investigation of their estrogen-like effects
  874. Preparation of Yangchunshenshu Capsule and Determination of icariin and Astragaloside
  875. Preparation Technology of Baohuoside Ⅰ by Enzymolysis of icariin with β-glucosidase [J]
  876. Preparation Technology of Total Saponins from Panax notoginseng Combined with icariin Chitosan Microspheres
  877. Preparation, pharmacokinetics, and tissue distribution properties of icariin-loaded stealth solid lipid nanoparticles in mice
  878. Progress of pharmacological research on icariin
  879. Proliferation and differentiation of periosteum cells induced by icariin
  880. Prophylactic treatment with icariin prevents isoproterenol-induced myocardial oxidative stress via nuclear Factor-Like 2 activation
  881. Protection against Aβ_ (25-35)-deprived injury in neurons by icariin [J]
  882. Protective effect of icariin against TGF-β1-induced injury of rat Leydig cells
  883. Protective effect of icariin on cigarette smoke extract induced inflammation in alveolar epithelial cells
  884. Protective effect of icariin on DNA against radical‐induced oxidative damage
  885. Protective effect of icariin on human umbilical vein endothelial cells injured by high glucose [J]
  886. Protective effect of icariin on kidney in 5/6 nephrectomized rats and its mechanism
  887. Protective effect of icariin on radiation damage in mice [J]
  888. Protective effect of icariin on radiation damage of Laydig cells in rats
  889. Protective effect of icariin on renal ischemia-reperfusion injury in rats and action mechanism
  890. Protective effect of icariin on the development of preimplantation mouse embryos against hydrogen peroxide-induced oxidative injury
  891. Protective effect of icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV …
  892. Protective effects of icariin against learning and memory deficits induced by aluminium in rats
  893. Protective effects of icariin on brain dysfunction induced by lipopolysaccharide in rats
  894. Protective effects of icariin on cisplatin-induced acute renal injury in mice
  895. Protective effects of icariin on cognitive deficits induced by chronic cerebral hypoperfusion in rats
  896. Protective effects of icariin on dorsal random skin flap survival: An experimental study
  897. Protective effects of icariin on human umbilical vein endothelial cell injury induced by H2O2 in vitro
  898. Protective effects of icariin on human vascular endothelial cells induced by oxidized low-density lipoprotein via modulating caspase-3 and Bcl-2
  899. Protective effects of icariin on lipopolysaccharide-induced acute renal injury in mice
  900. Protective effects of icariin on neurons injured by cerebral ischemia/reperfusion.
  901. Protective Effects of icariin on Nicotine-induced Reproductive Toxicity in Male Mouse
  902. Protective effects of icariin‑mediated SIRT1/FOXO3 signaling pathway on intestinal ischemia/reperfusion‑induced acute lung injury
  903. Purification of icariin from the extract of Epimedium segittatum using high-speed counter-current chromatography
  904. Purification of icariin-glycosidase and Its Enzymatic Characteristics [J]
  905. Qualitative and quantitative analysis of icariin analogues in Epimedium koreanum by UPLC-Q-TOF MS
  906. Quality evaluation of Epimedium sagittatum in different populations based on icariin contents
  907. Quantification of icariin in Anshen Bunao Ye by RP-HPLC [J]
  908. Quantitative Determination by HPLC-DAD of icariin, Epimedin A, Epimedin B, and Epimedin C in Epimedium (Berberidaceae) Species Growing in Turkey
  909. Quantitative determination of icariin and osthole in Gushudan decoction by RP-HPLC
  910. Quantitative determination of icariin in” tangzhi shuangjiang cha” by high performance liquid chromatography
  911. Rapid measurement of epimedin A, epimedin B, epimedin C, icariin, and moisture in Herba Epimedii using near infrared spectroscopy
  912. Reactive oxygen species involved in prenylflavonoids, icariin and icaritin, initiating cardiac differentiation of mouse embryonic stem cells
  913. Regio-selective deglycosylation of icariin by cell suspension cultures of Glycyrrhiza uralensis and Morus alba
  914. Regulation of Th17/Treg function contributes to the attenuation of chronic airway inflammation by icariin in ovalbumin-induced murine asthma model
  915. Relationships between icariin and anti-apoptotic miRNA-21 in mouse blastocyst development in vitro
  916. Relaxant Effects of icariin on the Rabbit Corpus Cavernosum and Its Mechanism
  917. Research advance in the pharmacological effects of icariin
  918. Research Advance in the Pharmacological Effects of icariin [J]
  919. Research Article Neuroprotective Activity of icariin Against Hypoxic-ischemic Brain Injury in Neonatal Rats
  920. Research on Extraction and Separation and Content Measuration of icariin [J]
  921. Research Progress of icariin Pharmacologic Action [J]
  922. Research progress on icariin in Herba Epimedii [J]
  923. Research progress on pharmacological action of icariin
  924. Resonance energy transfer, pH‐induced folded states and the molecular interaction of human serum albumin and icariin
  925. Role of IFT88 in icariin‑regulated maintenance of the chondrocyte phenotype
  926. Roles of calcium sensing receptor in icariin-induced differentiation of mouse embryonic stem cells to cardiomyocyte
  927. Roles of the antioxidant properties of icariin and its phosphorylated derivative in the protection against duck virus hepatitis
  928. RP-HPLC Determination of icariin in Huanchun Oral Solutions
  929. Screening of high icariin-glycosidase producing strain
  930. Screening of icariin glycosidase-secreting strains from soil
  931. Screening of microbal strains produced by icariin-glycosidase and its enzyme hydrolyzing condition
  932. Secretome analysis of rat osteoblasts during icariin treatment induced osteogenesis
  933. Self-assembly chitosan/gelatin composite coating on icariin-modified TiO2 nanotubes for the regulation of osteoblast bioactivity
  934. Separation and enrichment of icariin in extract of epimedium by solvent floatation
  935. Separation and Purification of Epimedin A, B, C, and icariin from the Medicinal Herb Epimedium brevicornum Maxim by Dual-Mode HSCCC
  936. Shared KEGG pathways of icariin‐targeted genes and osteoarthritis
  937. Signal pathway involved in regulation of Cbfa1 expression in osteoblasts by icariin
  938. Simultaneous assay of epimedin A epimedin B, epimedin C and icariin in herba epimedii by QAMS
  939. Simultaneous determination of contents of icariin and naringin in Gushukang granules by HPLC method [J]
  940. Simultaneous determination of danshensul and icariin in zhongliu Ⅰ capsule by HPLC
  941. Simultaneous determination of epimedin A, B, C and icariin in herba epimedii by high performance liquid chromatography
  942. Simultaneous determination of four saponins and icariin in “Qihuotongqiao” tablets by a high performance liquid chromatography—DAD method
  943. Simultaneous Determination of icariin and Naringin in Anti-osteoporosis Chinese Formulated Products by HPLC [J]
  944. Simultaneous determination of icariin and psoralen in Qiangyang Baoshen pills using HPLC method
  945. Simultaneous determination of icariin, icariside II and osthole in rat plasma after oral administration of the extract of Gushudan (a Chinese compound formulation) by …
  946. Simultaneous determination of icariin, naringin and osthole in rat plasma by UPLC–MS/MS and its application for pharmacokinetic study after oral administration of …
  947. Simultaneous determination of notoginsenoside R1, ginsenoside Rg1, Re, Rb1 and icariin in rat plasma by ultra-performance liquid chromatography-tandem mass …
  948. Simultaneous Determination of Panax Notoginseng Saponins and icariin in Guyu Injection by HPLC
  949. Simultaneous Determination of Salvianolic Acid B, icariin in Bindouling Oral Liquid by HPLC [J]
  950. Simultaneous determination of the contents of icariin and hyperoside in Qirong tablets by HPLC [J]
  951. Simultaneous extraction of epimedin A, B, C and icariin from Herba Epimedii by ultrasonic technique
  952. Simultaneous Preparation and Comparison of the Osteogenic Effects of Epimedins A – C and icariin from Epimedium brevicornu
  953. Slowly delivered icariin/allogeneic bone marrow-derived mesenchymal stem cells to promote the healing of calvarial critical-size bone defects
  954. Solubility of icariin in a Binary Solvent System of Ethanol and Water
  955. Spectroscopic investigation of the interactions of cryptotanshinone and icariin with two serum albumins
  956. Statistically designed enzymatic hydrolysis of an icariin/β-cyclodextrin inclusion complex optimized for production of icaritin
  957. Stimulatory effect of icariin on the proliferation of neural stem cells from rat hippocampus
  958. Studies on icariin by electrospray ionization mass spectrometry
  959. Study of icariin Affect on Learning and Memory in Senescence Accelerated Mouse Prone/8 (SAMP8)
  960. Study of molecular mechanisms of fuyuan capsule, icariin and arasaponin R1 in treatment of osteoarthritis
  961. Study of PNIPAAm-PEG thermo-sensitive copolymer micelle and Application as drug carrier for icariin
  962. Study of preparation of icariin nanopaticles and their effect on human osteoblast cells
  963. Study of the interaction between icariin and human serum albumin by fluorescence spectroscopy
  964. Study on Acid Hydrolysis Condition of icariin Glycoside [J]
  965. Study on antioxidant activity of icariin and its derivatives
  966. Study on different factors affecting the bionic enzymatic hydrolysis of icariin
  967. Study on effect of icariin on the immune function in mice [J]
  968. Study on extraction process for the icariin of hugu capsule with ultrasonic technology
  969. Study on Extraction Processes of icariin [J]
  970. Study on Flash-type Extraction Process for Total Flavonoids and icariin from Herba Epimedii [J]
  971. Study on Hydrolysis of icariin Glycoside to Anhydroicaritin
  972. Study on Improvement Effect and Mechanism of icariin on Renal Lesion in Rats with Spontaneous Hyper-tension
  973. Study on in situ intestinal absorption kinetics of icariin in rats
  974. Study on induction of icariin on directional differentiation of embryonic stem cells into cardiomyocytes in vitro
  975. Study on Influence of Compatibility on icariin in Shentong Granules by HPLC [J]
  976. Study on pharmacokinetics of icariin loaded solid lipid nanoparticles in rats
  977. Study on preparation of icaritin by enzymolysis of icariin with snail hydrolase
  978. Study on quick extraction and determination of icariin from Herba Epimedii
  979. Study on Separation and Purification of icariin of Herba Epimedii [J]
  980. Study on the Determination of the Content of icariin in Yinyangsuo Granula
  981. Study on the interaction of hesperidin or icariin with lysozyme by fluorescence spectroscopy
  982. Study on the intervention of icariin in immunosenescence via NF-κB signaling pathway
  983. Symbol Different concentrations of icariin for bone defect repair: disputes and exploration
  984. Symbol icariin inhibits orthodontically induced inflammatory root resorption
  985. Symbol Promotive effect of injectable thermo-sensitive icariin chitosan hydrogel on radial fracture healing in rabbits
  986. SymbolControlled-release icariin loaded-hydroxyapatite/chitosan scaffold for repair of bone defects
  987. Synergistic anti-cancer effects of icariin and temozolomide in glioblastoma
  988. Synergistic or Antagonistic Effect of MTE plus TF or icariin from Epimedium koreanum on the Proliferation and Differentiation of Primary Osteoblasts In Vitro
  989. Synergistic osteogenesis between icariin and bone morphogenetic protein 2: A potential osteogenic compound for bone tissue engineering
  990. Synthesis and antibacterial activity of novel icariin derivatives
  991. Synthesis and antimultidrug resistance evaluation of icariin and its derivatives
  992. Synthesis of icariin from kaempferol through regioselective methylation and para-Claisen–Cope rearrangement
  993. The antifibrotic and anti-inflammatory effects of icariin on the kidney in a unilateral ureteral obstruction mouse model
  994. The antioxidative effect of icariin in human erythrocytes against free‐radical‐induced haemolysis
  995. The anti-proliferative effect of icariin combined with mitomycin on the HepG2 cells [J]
  996. The beneficial effect of icariin on bone is diminished in osteoprotegerin-deficient mice
  997. The Beneficial Effect of Proanthocyanidins and icariin on Biochemical Markers of Bone Turnover in Rats
  998. The Cardioprotective Effect of icariin on Ischemia–Reperfusion Injury in Isolated Rat Heart: Potential Involvement of the PI 3 K‐A kt Signaling Pathway
  999. The cardioprotective effects of icariin on the isoprenaline-induced takotsubo-like rat model: Involvement of reactive oxygen species and the TLR4/NF-κB signaling …
  1000. The Combination of icariin and constrained dynamic loading stimulation attenuates bone loss in ovariectomy‐induced osteoporotic mice
  1001. The Contents of General Flavone, icariin and Chlorogenic Acid in Epimedium wushanense and Its Differently-processed Products [J]
  1002. The dose-effect of icariin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cells
  1003. The effect of icariin and astragalosid I on the proliferation and differentiation of bone marrow stromal cells
  1004. The effect of icariin on bone metabolism and its potential clinical application
  1005. The effect of icariin on growth and ECM secretion of chondrocytes cultured in collagen scaffold [J]
  1006. The effect of icariin on immunity and its potential application
  1007. The effect of icariin on prolifetration and differentiation of osteoblasts in vitro
  1008. The effect of icariin on promoting neurogenesis and angiogenesis and its mechanism
  1009. The Effect of icariin on the Expression of RANKL and Wnt3a in the Pressure Zone of Periodontal Tissue During Orthodontic Tooth Movement
  1010. The effect of icariin on the proliferation and osteogenic differentiation of human dental pulp stem cells
  1011. The Effect of icariin on the Vasorelaxant Function of Isolated Rat Thoracic Aortic Rings and the Pressure of Left Ventricle
  1012. The effect of loading icariin on biocompatibility and bioactivity of porous β-TCP ceramic
  1013. The effects of electrospun nanofibers loading icariin on osteoblast MC3T3-E1 cells
  1014. The effects of icariin in inflammatory rat model for AD of TNF-a mRNA, IL-6mRNA expression
  1015. The effects of icariin on enhancing motor recovery through attenuating pro-inflammatory factors and oxidative stress via mitochondrial apoptotic pathway in the mice …
  1016. The Effects of icariin on Expression of OPN mRNA after Vascular Injury in Rats
  1017. The effects of icariin on the expression of HIF-1α, HSP-60 and HSP-70 in PC12 cells suffered from oxygen–glucose deprivation-induced injury
  1018. The effects of icariin on wound healing of extraction sites with administration of zoledronic and dexamethasone: A rat model study
  1019. The effects of the different precipitating methods on the content of icariin, ferulic acid and tanshinone ⅡA in Xingnaoyizhi granules
  1020. The effects of three kinds of precipitator on the content of ferulic acid and icariin in Yangxuefuzheng granules
  1021. The enhancement of icariin on the apoptosis of HCY induced proliferating vascular smooth musle cells [J]
  1022. The experiment study of the effects of icariin on Smad1, 5 in MC3T3-E1 cell in vitro.
  1023. The experimental research of icariin affecting inflammatory factors related to prosthesis loosening [J]
  1024. The experimental study of the effects of icariin on increasing smad4 mRNA level in MC3T3-E1 cell in vitro
  1025. The Experimental Study on Anti-exercise-induced Fatigue of Rat of the icariin [J]
  1026. The flavonol glycoside icariin promotes bone formation in growing rats by activating the cAMP signaling pathway in primary cilia of osteoblasts
  1027. The HPLC Method and the TLC-UV Method for Determination of Mass Concentration of icariin in Herba Epimed
  1028. The in vivo anti-tumor effects of icariin and its mechanisms
  1029. The in vivo study of the effect of icariin on ECM secretion and gene expression of chondrocytes
  1030. The influences of icariin on SDF-1 and CXCR-4 of rats with acute ischemic stroke and study on its protection function for nerve.
  1031. The inhibitory function of icariin in cell model of benign prostatic hyperplasia by upregulation of miR‐7
  1032. The neuroprotective effect of icariin in the cell model of Parkinson
  1033. The Optimum Process of Extracting icariin by High Pressure Method
  1034. The pharmacological research advance of icariin.
  1035. The protection effects and mechanisms of icariin against concanavalin A-induced liver injury in mice.
  1036. The protective effect of icariin and phosphorylated icariin against LPS-induced intestinal epithelial cells injury
  1037. The protective effect of icariin and phosphorylated icariin against LPS-induced intestinal goblet cell dysfunction
  1038. The protective effect of icariin on mitochondrial transport and distribution in primary hippocampal neurons from 3× Tg-AD mice
  1039. The protective effects of icariin against the homocysteine-induced neurotoxicity in the primary embryonic cultures of rat cortical neurons
  1040. The reason leading to the increase of icariin in Herba Epimedii by heating process
  1041. The regulatory role of icariin on apoptosis in mouse preimplantation embryos with reduced microRNA-21
  1042. The Roles of icariin on the Proliferation and Apoptosis Abilities of Human Oophoroma Cells and Multi-drug Resistant Cell Line
  1043. The testosterone mimetic properties of icariin
  1044. The TLC Identification for Four Medicinal Materials and the Determination of icariin in Tianshenyizhi Capsule [J]
  1045. Therapeutic effect of icariin combined with stem cells on postmenopausal osteoporosis in rats
  1046. Three-dimensional printing beta-tricalcium phosphate scaffold loaded with icariin particles for repairing osteonecrosis of the femoral head in rabbits
  1047. Tissue-engineered bone constructed by icariin-induced periosteal cells repairs bone defects
  1048. Tissues distribution of icariin and its metabolites in kidney of osteoporosis model rats
  1049. Total flavonoids and icariin contents of Epimedium pubescens in different types of communities and their relationships with soil factors.
  1050. Trace analysis of icariin in human serum with dansyl chloride derivatization after oral administration of Epimedium decoction by liquid chromatography tandem mass …
  1051. Transformation of icariin by immobilized β-glucosidase and snailase
  1052. Ultrasonic-assisted Extraction of icariin from Epimedium macranthum Leaves and Their Stability
  1053. Uncertainty analysis of content determination of icariin in Huangmai mixture by HPLC method
  1054. UPLC-MS/MS for the pharmacokinetics of icariin in rats
  1055. Use of an osteoblast overload damage model to probe the effect of icariin on the proliferation, differentiation and mineralization of MC3T3-E1 cells through the Wnt/β …
  1056. Variation in icariin and flavonoid contents of barrenwort accessions native to Guizhou, China
  1057. Variation in icariin and flavonoid contents of Barrenwort species
  1058. Variation of Epimedins A – C and icariin in Ten Representative Populations of Epimedium brevicornu Maxim., and Implications for Utilization
  1059. Variation of icariin and total flavonoid of Epimedium acuminatum in different parts and habitats
  1060. Vasorelaxant effects of icariin on isolated canine coronary artery
  1061. Versatile solid modifications of icariin: structure, properties and form transformation
  1062. Wnt/β-catenin signaling is involved in the icariin induced proliferation of bone marrow mesenchymal stem cells
  1063. Yizhijiannao Granule and a combination of its effective monomers, icariin and Panax notoginseng saponins, inhibit early PC12 cell apoptosis induced by beta …

Related Posts

Shopping Cart
Scroll to Top